[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 51 of about 51
1. Maître B, Mangin PH, Eckly A, Heim V, Cazenave JP, Lanza F, Hanau D, Gachet C: Immature myeloid dendritic cells capture and remove activated platelets from preformed aggregates. J Thromb Haemost; 2010 Oct;8(10):2262-72

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: In this study, we investigated whether platelets can recruit immature myeloid DCs (CD1c(+) ) directly isolated from blood (BDCs) and if so, which receptors are involved.
  • RESULTS: Using flow cytometry and electron microscopy, we showed that BDCs interact with activated but not resting platelets in suspension.
  • Interaction was also observed after perfusing BDCs under low flow conditions (150 s(-1) ) through collagen-coated microcapillaries in which platelets had adhered and formed aggregates.
  • Whereas initial transient attachment required the exposure of P-selectin on activated platelets and PSGL-1 on BDCs, subsequent stationary adhesion was dependent on α(IIb) β(3) and α(M) β(2) integrins on platelets and BDCs, respectively.
  • Moreover, during their transient interaction, BDCs preferentially removed platelets located at the outer margin of the thrombus in a P-selectin- and integrin-dependent manner.
  • [MeSH-minor] Blood Platelets / cytology. Cell Adhesion. Flow Cytometry / methods. Humans. Macrophage-1 Antigen / metabolism. Membrane Glycoproteins / metabolism. Microscopy, Confocal / methods. Microscopy, Electron / methods. P-Selectin / metabolism. Platelet Adhesiveness. Platelet Glycoprotein GPIIb-IIIa Complex / metabolism. Stress, Mechanical

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 International Society on Thrombosis and Haemostasis.
  • (PMID = 20633211.001).
  • [ISSN] 1538-7836
  • [Journal-full-title] Journal of thrombosis and haemostasis : JTH
  • [ISO-abbreviation] J. Thromb. Haemost.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Macrophage-1 Antigen; 0 / Membrane Glycoproteins; 0 / P-Selectin; 0 / P-selectin ligand protein; 0 / Platelet Glycoprotein GPIIb-IIIa Complex
  •  go-up   go-down


2. Oğuz S, Enç N, Yiğit Z: [Adaptation of the compliance and belief scales to Turkish for patients with chronic heart failure]. Turk Kardiyol Dern Ars; 2010 Oct;38(7):480-5
MedlinePlus Health Information. consumer health - Heart Failure.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: We evaluated the validity and reliability of the Turkish versions of the Beliefs about Medication Compliance Scale (BMCS), Beliefs about Dietary Compliance Scale (BDCS), and Beliefs about Self-Monitoring Scale (BSMS) for patients with chronic heart failure (CHF).
  • Cronbach alpha coefficients of the benefit and barrier subscales at the first interview were 0.74 and 0.59 for the BMCS, 0.71 and 0.58 for the BDCS, and 0.77 and 0.68 for the BSMS, respectively.
  • Interclass correlation coefficients for test-retest reliability for the benefit and barrier subscales were as follows: 0.90 and 0.91 for the BMCS, 0.86 and 0.86 for the BDCS, and 0.90 and 0.93 for the BSMS, respectively.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21206201.001).
  • [ISSN] 1016-5169
  • [Journal-full-title] Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır
  • [ISO-abbreviation] Turk Kardiyol Dern Ars
  • [Language] tur
  • [Publication-type] English Abstract; Journal Article; Validation Studies
  • [Publication-country] Turkey
  •  go-up   go-down


3. Facci MR, Auray G, Buchanan R, van Kessel J, Thompson DR, Mackenzie-Dyck S, Babiuk LA, Gerdts V: A comparison between isolated blood dendritic cells and monocyte-derived dendritic cells in pigs. Immunology; 2010 Mar;129(3):396-405

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Various dendritic cell (DC) populations exist that differ in phenotype and ability to present antigen to T cells.
  • For example, plasmacytoid DCs (pDCs) are less potent T cell activators compared with conventional DCs (cDCs).
  • Here, we compared porcine blood DCs (BDCs), containing pDCs and cDCs, and monocyte-derived DCs (MoDC), consisting of cDCs, in their phenotype, ability to uptake antigen, activation and maturation and their ability to present antigen to autologous T cells.
  • Although basal and post-stimulation protein concentrations of interleukins 6 and 8 and tumour necrosis factor-alpha were higher in MoDCs, protein concentrations showed a higher fold increase in BDCs.
  • Antigen-specific proliferation of autologous T cells was induced by MoDCs and BDCs.
  • These results demonstrate that isolated porcine BDCs are highly responsive to stimulation with lipopolysaccharide and are functionally able to drive primed T-cell proliferation to the same extent as MoDCs.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Science. 2000 Oct 6;290(5489):92-7 [11021806.001]
  • [Cites] J Exp Med. 2000 Feb 21;191(4):743-8 [10684866.001]
  • [Cites] Vet Immunol Immunopathol. 2001 Jul 20;80(1-2):93-109 [11445221.001]
  • [Cites] Cell. 2001 Aug 10;106(3):255-8 [11509172.001]
  • [Cites] Immunology. 2001 Oct;104(2):175-84 [11683958.001]
  • [Cites] Blood. 2002 Aug 15;100(4):1362-72 [12149219.001]
  • [Cites] Trends Immunol. 2002 Sep;23(9):445-9 [12200066.001]
  • [Cites] Vet Immunol Immunopathol. 2003 Feb 10;91(3-4):183-97 [12586481.001]
  • [Cites] J Exp Med. 2003 Apr 7;197(7):899-906 [12668648.001]
  • [Cites] Immunology. 2003 Dec;110(4):440-9 [14632641.001]
  • [Cites] J Virol. 2003 Dec;77(24):13288-300 [14645585.001]
  • [Cites] Immunology. 2004 May;112(1):28-37 [15096181.001]
  • [Cites] Vaccine. 2004 Feb 25;22(8):1016-23 [15161079.001]
  • [Cites] J Gen Virol. 2004 Jun;85(Pt 6):1633-41 [15166448.001]
  • [Cites] J Exp Med. 1992 Jul 1;176(1):287-92 [1613462.001]
  • [Cites] Infect Immun. 1993 Oct;61(10):4452-61 [7691750.001]
  • [Cites] Blood. 1997 May 15;89(10):3708-16 [9160676.001]
  • [Cites] Nature. 1997 Aug 21;388(6644):787-92 [9285592.001]
  • [Cites] Springer Semin Immunopathol. 2005 Jan;26(3):289-307 [15609003.001]
  • [Cites] Immunology. 2005 Feb;114(2):204-12 [15667565.001]
  • [Cites] Immunology. 2005 Jul;115(3):388-98 [15946256.001]
  • [Cites] Vet Immunol Immunopathol. 2005 Sep 15;107(3-4):235-47 [15998543.001]
  • [Cites] Vet Immunol Immunopathol. 2006 Jun 15;111(3-4):175-85 [16476491.001]
  • [Cites] Vet Immunol Immunopathol. 2006 Dec 15;114(3-4):224-37 [16978709.001]
  • [Cites] Vet Immunol Immunopathol. 2007 Jan 15;115(1-2):56-67 [17070934.001]
  • [Cites] Nat Rev Immunol. 2007 Jan;7(1):19-30 [17170756.001]
  • [Cites] Arch Virol. 2007 Feb;152(2):289-303 [17031757.001]
  • [Cites] Trends Immunol. 2007 May;28(5):227-33 [17403614.001]
  • [Cites] Gene Ther. 2007 May;14(10):836-44 [17330086.001]
  • [Cites] Immunity. 2007 Jun;26(6):741-50 [17582346.001]
  • [Cites] Semin Immunol. 2007 Dec;19(6):353-61 [18023589.001]
  • [Cites] Nat Rev Immunol. 2008 May;8(5):362-71 [18379575.001]
  • [Cites] Vet Immunol Immunopathol. 2008 Jun 15;123(3-4):324-36 [18367252.001]
  • [Cites] J Virol. 2008 Jul;82(13):6379-94 [18448534.001]
  • [Cites] Nat Protoc. 2008;3(6):1101-8 [18546601.001]
  • [Cites] Immunol Cell Biol. 2008 Jul;86(5):439-52 [18414430.001]
  • [Cites] Immunity. 2008 Sep 19;29(3):352-61 [18799143.001]
  • [Cites] J Microbiol Biotechnol. 2008 Oct;18(10):1709-16 [18955824.001]
  • [Cites] Dev Comp Immunol. 2009 Mar;33(3):299-309 [18582937.001]
  • [Cites] Mol Immunol. 2009 Jan;46(3):437-47 [19036453.001]
  • [Cites] Immunology. 2001 Apr;102(4):396-404 [11328373.001]
  • (PMID = 19922422.001).
  • [ISSN] 1365-2567
  • [Journal-full-title] Immunology
  • [ISO-abbreviation] Immunology
  • [Language] ENG
  • [Grant] Canada / Canadian Institutes of Health Research / /
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / CCR7 protein, human; 0 / Chemokines; 0 / Cytokines; 0 / Lipopolysaccharides; 0 / Receptors, CCR7; 0 / fluorescein isothiocyanate dextran; 9006-59-1 / Ovalbumin; I223NX31W9 / Fluorescein-5-isothiocyanate; K3R6ZDH4DU / Dextrans
  • [Other-IDs] NLM/ PMC2826684
  •  go-up   go-down


Advertisement
4. Arshad R, Farooq S, Iqbal N, Ali SS: Mutagenic effect of acridine orange on the expression of penicillin G acylase and beta-lactamase in Escherichia coli. Lett Appl Microbiol; 2006 Feb;42(2):94-101

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS AND RESULTS: Three wild E. coli strains BDCS-N-FMu10, BDCS-N-S21 and BDCS-N-W50, producing both the enzymes PGA and beta-lactamase were treated by AO.
  • One of the mutant strains (BDCS-N-M36) exhibited very negligible expression of beta-lactamase activity and twofold increase in PGA activity [12.7 mg 6-amino-penicillanic acid (6-APA) h(-1) mg(-1) wet cells] compared with that in the wild-type strain (6.3 mg 6-APA h(-1) mg(-1) wet cells).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16441371.001).
  • [ISSN] 0266-8254
  • [Journal-full-title] Letters in applied microbiology
  • [ISO-abbreviation] Lett. Appl. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] EC 3.5.1.11 / Penicillin Amidase; EC 3.5.2.6 / beta-Lactamases; F30N4O6XVV / Acridine Orange
  •  go-up   go-down


5. Wang B, Jiao Z, Shao X, Lu L, Yang N, Zhou X, Xin L, Zhou Y, Chou KY: Phenotypic alterations of dendritic cells are involved in suppressive activity of trichosanthin-induced CD8+CD28- regulatory T cells. J Immunol; 2010 Jul 1;185(1):79-88

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The suppression is evoked only if bone marrow-derived dendritic cells (BDCs) instead of purified T cells are treated with Tk in an OVA-specific T-BDC interaction.
  • Moreover, a special pattern of cytokine/transcription factors (IL-4(+)IL-10(+)IFN-gamma(-)Gata3(+)T-bet(-)) during suppressed OVA-specific T cell proliferation was observed in HS C57BL/6 but not in low-susceptible C3H/He mice.
  • Additionally, obvious alterations of phenotypic parameters of BDCs after Tk stimulation were also identified, including enhanced production of IL-10, decreased secretion of IL-12, and detection of Jagged1, a Notch ligand on BDCs.
  • [MeSH-minor] Animals. Cell Line. Cells, Cultured. Coculture Techniques. Genetic Predisposition to Disease. Lymphocyte Activation / immunology. Male. Mice. Mice, Inbred AKR. Mice, Inbred BALB C. Mice, Inbred C3H. Mice, Inbred C57BL. Mice, Inbred DBA. Species Specificity

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20498361.001).
  • [ISSN] 1550-6606
  • [Journal-full-title] Journal of immunology (Baltimore, Md. : 1950)
  • [ISO-abbreviation] J. Immunol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD28; 0 / Antigens, CD8; 60318-52-7 / Trichosanthin
  •  go-up   go-down


6. Smolewska E, Cebula B, Brózik H, Stańczyk J: Relationship between impaired apoptosis of lymphocytes and distribution of dendritic cells in peripheral blood and synovial fluid of children with juvenile idiopathic arthritis. Arch Immunol Ther Exp (Warsz); 2008 Jul-Aug;56(4):283-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Recently the present authors described disturbed apoptosis of JIA lymphocytes in both peripheral blood (PB) and synovial fluid (SF) as well as an abnormal distribution of blood dendritic cells (BDCs) between the PB and SF in this disease.
  • CONCLUSIONS: These data suggest a possible link between impaired apoptosis of PB/SF lymphocytes and increased recruitment of PB BDCs to SF and other elements of the immune system in JIA, including regulatory CD4+/CD25high cells.

  • Genetic Alliance. consumer health - Arthritis.
  • Genetic Alliance. consumer health - Arthritis, Juvenile.
  • MedlinePlus Health Information. consumer health - Juvenile Arthritis.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arthritis Res. 2002;4(3):177-83 [12010567.001]
  • [Cites] Am J Transplant. 2005 Dec;5(12):2945-53 [16303009.001]
  • [Cites] Ann Rheum Dis. 2003 Aug;62(8):761-3 [12860732.001]
  • [Cites] J Immunol Methods. 2004 Feb 15;285(2):215-21 [14980435.001]
  • [Cites] Scand J Rheumatol. 2004;33(1):7-12 [15124936.001]
  • [Cites] J Immunol. 2004 May 15;172(10):6435-43 [15128835.001]
  • [Cites] Arthritis Res Ther. 2004;6(4):R335-46 [15225369.001]
  • [Cites] J Immunol. 2004 Aug 15;173(4):2815-24 [15295000.001]
  • [Cites] Clin Exp Immunol. 1986 Mar;63(3):594-600 [2940038.001]
  • [Cites] Blood. 1997 Nov 1;90(9):3245-87 [9345009.001]
  • [Cites] J Rheumatol. 1998 Oct;25(10):1991-4 [9779856.001]
  • [Cites] Rheumatology (Oxford). 1999 Apr;38(4):325-8 [10378709.001]
  • [Cites] J Rheumatol Suppl. 2005 Feb;73:14-8; discussion 29-30 [15693111.001]
  • [Cites] Am J Respir Cell Mol Biol. 2005 Mar;32(3):177-84 [15576669.001]
  • [Cites] Arthritis Res Ther. 2005;7(2):R230-40 [15743469.001]
  • [Cites] Arthritis Res Ther. 2005;7(3):93 [15899057.001]
  • [Cites] J Rheumatol. 2006 Aug;33(8):1684-90 [16881124.001]
  • [Cites] Am J Respir Cell Mol Biol. 2006 Sep;35(3):387-93 [16627825.001]
  • [Cites] Rheumatology (Oxford). 2007 Apr;46(4):657-65 [17085467.001]
  • [Cites] Clin Exp Rheumatol. 2007 Sep-Oct;25(5 Suppl 46):S4-11 [17977483.001]
  • [Cites] J Immunol. 2000 Dec 1;165(11):6037-46 [11086035.001]
  • [Cites] Clin Rheumatol. 2001;20(1):30-5 [11254238.001]
  • [Cites] J Immunol. 2001 Aug 1;167(3):1758-68 [11466401.001]
  • [Cites] Bone Marrow Transplant. 2001 Sep;28(5):439-45 [11593316.001]
  • [Cites] Arthritis Res Ther. 2007;9(4):219 [17850683.001]
  • [Cites] J Microbiol Immunol Infect. 2008 Feb;41(1):78-87 [18327431.001]
  • [Cites] Ann Rheum Dis. 2008 Jun;67(6):762-8 [17965117.001]
  • [Cites] Blood. 2002 Dec 15;100(13):4512-20 [12393628.001]
  • (PMID = 18726149.001).
  • [ISSN] 0004-069X
  • [Journal-full-title] Archivum immunologiae et therapiae experimentalis
  • [ISO-abbreviation] Arch. Immunol. Ther. Exp. (Warsz.)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Chemical-registry-number] 0 / Tumor Necrosis Factor-alpha
  • [Other-IDs] NLM/ PMC2778712
  •  go-up   go-down


7. Arshad R, Farooq S, Ali SS: Improvement of penicillin G acylase expression in Escherichia coli through UV induced mutations. Braz J Microbiol; 2010 Oct;41(4):1133-41

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The best hyper-producing mutant (BDCS-N-M74), with almost negligible expression of β-lactamase, exhibited three-fold (22.5 mg 6-APA h(-1) mg(-1) wet cells) increase in PGA activity compared with that in the parent strain (6.7 mg 6-APA h(-1) mg(-1) wet cells).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24031596.001).
  • [ISSN] 1517-8382
  • [Journal-full-title] Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
  • [ISO-abbreviation] Braz. J. Microbiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Brazil
  • [Other-IDs] NLM/ PMC3769778
  • [Keywords] NOTNLM ; Escherichia coli / UV irradiation / mutation / penicillin G acylase expression
  •  go-up   go-down


8. Radford KJ, Turtle CJ, Kassianos AJ, Vuckovic S, Gardiner D, Khalil D, Taylor K, Wright S, Gill D, Hart DN: Immunoselection of functional CMRF-56+ blood dendritic cells from multiple myeloma patients for immunotherapy. J Immunother; 2005 Jul-Aug;28(4):322-31
MedlinePlus Health Information. consumer health - Multiple Myeloma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To validate this as a feasible source of BDCs for immunotherapy, the authors undertook a quantitative and functional analysis of BDCs in MM patients and healthy donors.
  • These data show that MM patients have similar numbers of CD11c+CD16+ and CD11c+CD16- BDCs but about half the number of CD11c-CD123+ BDCs in whole blood compared with healthy donors.
  • BDCs could be isolated by CMRF-56+ immunoselection from all MM patients tested, with similar yields and purity to healthy donors.
  • These BDCs could be activated ex vivo with poly I:C or LPS.
  • These data suggest that BDCs with in vitro functional integrity can be isolated from MM patients in sufficient numbers to justify a clinical trial.
  • [MeSH-minor] Aged. Antigen Presentation / immunology. Antigens, CD / metabolism. Antigens, CD11c / immunology. Cell Survival / immunology. Cytokines / metabolism. HLA-D Antigens / immunology. Histocompatibility Antigens Class I / immunology. Humans. Interferon-gamma / metabolism. Interleukin-3 Receptor alpha Subunit. Leukocyte Count. Leukocytes, Mononuclear / cytology. Leukocytes, Mononuclear / immunology. Lipopolysaccharides / pharmacology. Lymphocyte Activation / immunology. Middle Aged. Poly I-C / pharmacology. Receptors, Interleukin-3 / immunology. T-Lymphocytes / immunology. Up-Regulation / immunology

  • Genetic Alliance. consumer health - Multiple myeloma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16000950.001).
  • [ISSN] 1524-9557
  • [Journal-full-title] Journal of immunotherapy (Hagerstown, Md. : 1997)
  • [ISO-abbreviation] J. Immunother.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD11c; 0 / Antigens, Differentiation; 0 / CMRF-56 antigen; 0 / Cytokines; 0 / HLA-D Antigens; 0 / Histocompatibility Antigens Class I; 0 / IL3RA protein, human; 0 / Interleukin-3 Receptor alpha Subunit; 0 / Lipopolysaccharides; 0 / Receptors, Interleukin-3; 24939-03-5 / Poly I-C; 82115-62-6 / Interferon-gamma
  •  go-up   go-down


9. Radford KJ, Turtle CJ, Kassianos AJ, Hart DN: CD11c+ blood dendritic cells induce antigen-specific cytotoxic T lymphocytes with similar efficiency compared to monocyte-derived dendritic cells despite higher levels of MHC class I expression. J Immunother; 2006 Nov-Dec;29(6):596-605
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Dendritic cell (DC) immunotherapy for cancer has shown promising results in phase I and II clinical trials.
  • The natural circulating peripheral blood CD11c+ DC precursors (BDCs) may be an attractive alternative to MoDCs, as they can be isolated rapidly in sufficient quantities, and have superior migratory and T helper-1-inducing capacity in vitro.
  • We performed the first comparative analysis of the ability of autologous BDCs and MoDCs in healthy donors to induce tumor-specific cytotoxic T lymphocytes (CTLs).
  • BDCs expressed significantly higher levels of major histocompatibility complex class I and CD83 in the absence of exogenous stimuli compared with MoDCs.
  • After activation with polyinosinic-polycytidylic acid, BDCs expressed higher levels of major histocompatibility complex class I, CD40, CD80, and CD83, and secreted higher levels of tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, and IL-8 compared with MoDCs.
  • The ability of BDCs to induce efficient CTL responses, combined with their migratory capacity, makes them an appealing alternative to be investigated in clinical immunotherapy research protocols.
  • [MeSH-minor] Antigens, CD / metabolism. Antigens, Differentiation / metabolism. Antigens, Neoplasm / immunology. CD40 Ligand / pharmacology. Cell Line, Tumor. Cytokines / metabolism. Cytokines / pharmacology. Cytotoxicity Tests, Immunologic. HLA-A Antigens / immunology. HLA-A2 Antigen. HLA-DR Antigens / metabolism. Humans. Interferon-gamma / metabolism. Interleukin-12 / metabolism. Leukocytes, Mononuclear / cytology. Leukocytes, Mononuclear / drug effects. Leukocytes, Mononuclear / immunology. Lymphocyte Activation / drug effects. Lymphocyte Activation / immunology. MART-1 Antigen. Monocytes / cytology. Monocytes / drug effects. Monocytes / immunology. Neoplasm Proteins / immunology. Peptide Fragments / immunology. Poly I-C / pharmacology. Toll-Like Receptor 3 / metabolism. Viral Matrix Proteins / immunology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17063122.001).
  • [ISSN] 1524-9557
  • [Journal-full-title] Journal of immunotherapy (Hagerstown, Md. : 1997)
  • [ISO-abbreviation] J. Immunother.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / Antigens, CD11c; 0 / Antigens, Differentiation; 0 / Antigens, Neoplasm; 0 / CMRF-56 antigen; 0 / Cytokines; 0 / HLA-A Antigens; 0 / HLA-A*02:01 antigen; 0 / HLA-A2 Antigen; 0 / HLA-DR Antigens; 0 / Histocompatibility Antigens Class I; 0 / MART-1 Antigen; 0 / MLANA protein, human; 0 / Neoplasm Proteins; 0 / Peptide Fragments; 0 / TLR3 protein, human; 0 / Toll-Like Receptor 3; 0 / Viral Matrix Proteins; 0 / influenza matrix peptide (58-66); 147205-72-9 / CD40 Ligand; 187348-17-0 / Interleukin-12; 24939-03-5 / Poly I-C; 82115-62-6 / Interferon-gamma
  •  go-up   go-down


10. Arshad R, Farooq S, Ali SS: Comparative production of 6-aminopenicillanic acid by different E. coli strains and their acridine orange (AO) induced mutants. Pak J Biol Sci; 2007 Nov 1;10(21):3931-5
Hazardous Substances Data Bank. PENICILLIN G .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Relative PGA activity of local and foreign E. coli strains varied significantly with the highest being 12.7 in mutant strain (BDCS-N-M36) and the lowest 4.3 mg 6-APA h(-1) mg(-1) wet cells in foreign strain (ATCC 11105).
  • The enzyme activity exhibited by mutant strain (BDCS-N-M36) was also two folds higher compared to that in wild parent BDCS-N-W50 (6.3 mg 6-APA h(-1) mg(-1) wet cells).
  • Maximum conversion ratio (83%) was achieved by using crude cells of mutant strain (BDCS-N-M36) which is the highest value ever reported by crude cells on a shake-flask scale whereas reported 6-APA production by immobilized cells is 60-90% in batch and continuous systems.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19090257.001).
  • [ISSN] 1028-8880
  • [Journal-full-title] Pakistan journal of biological sciences : PJBS
  • [ISO-abbreviation] Pak. J. Biol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  • [Chemical-registry-number] 0 / Fluorescent Dyes; 87-53-6 / Penicillanic Acid; F30N4O6XVV / Acridine Orange; Q42T66VG0C / Penicillin G; QR0C4R7XVN / aminopenicillanic acid
  •  go-up   go-down


11. Auray G, Facci MR, van Kessel J, Buchanan R, Babiuk LA, Gerdts V: Differential activation and maturation of two porcine DC populations following TLR ligand stimulation. Mol Immunol; 2010 Jul;47(11-12):2103-11
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Compounds that trigger PRRs are potential vaccine adjuvants, hence in this study we stimulated two porcine DC populations, namely monocyte-derived DCs (MoDCs) and blood DCs (BDCs), with a broad range of toll-like receptors (TLRs) ligands and assessed the activation/maturation state of these porcine DCs.
  • In order to determine if TLR ligands would have an effect on porcine DCs, we characterized the expression of TLRs and demonstrated that MoDCs and BDCs expressed the same set of TLRs but at different levels.
  • The most effective in inducing BDCs activation were LPS and class A CpG oligodeoxynucleotide (ODN), resulting in up-regulation of chemokine receptor (CCR)7 and down-regulation of CCR2 and CCR5, production of IL-12p40, and expression of a broad range of chemokines that were able to attract porcine immune cells.

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Elsevier Ltd. All rights reserved.
  • (PMID = 20462636.001).
  • [ISSN] 1872-9142
  • [Journal-full-title] Molecular immunology
  • [ISO-abbreviation] Mol. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Cytokines; 0 / Ligands; 0 / Receptors, CCR2; 0 / Receptors, CCR5; 0 / Toll-Like Receptors
  •  go-up   go-down


12. Welch JL, Bennett SJ, Delp RL, Agarwal R: Benefits of and barriers to dietary sodium adherence. West J Nurs Res; 2006 Mar;28(2):162-80; discussion 181-9
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This study's purpose, based on the health belief model, was to evaluate the reliability and validity of the Beliefs about Dietary Compliance Scale (BDCS), describe perceived benefits and barriers over time, and identify individual benefits and barriers that may be amenable to tailored interventions.
  • A convenience sample of 229 completed the BDCS at baseline.
  • One week after baseline, 52 participants completed the BDCS to assess test-retest reliability.

  • MedlinePlus Health Information. consumer health - Sodium.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16513918.001).
  • [ISSN] 0193-9459
  • [Journal-full-title] Western journal of nursing research
  • [ISO-abbreviation] West J Nurs Res
  • [Language] eng
  • [Grant] United States / NINR NIH HHS / NR / R01 NR05347
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Sodium, Dietary
  •  go-up   go-down


13. Arshad R, Farooq S, Ali SS: 6-aminopenicillanic acid production by intact cells of E. coli containing penicillin G acylase (PGA). Pak J Biol Sci; 2007 Sep 15;10(18):3190-4
Hazardous Substances Data Bank. OXYGEN .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The maximum PGA activity was observed in Escherichia coli strain BDCS-N-FMu12 (6.4 mg 6-APA h(-1) mg(-1) wet cells) whereas Bacillus megaterium (ATCC 14945 used as check) exhibited only 2.4 mg 6-APA h(-1) mg(-1) wet cells.
  • BDCS-N-FMu12 was identified as the best PGA producer with 68% 6-APA conversion whereas ATCC 14945 showed the lowest conversion (37%).

  • Hazardous Substances Data Bank. PHENYLACETIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19090124.001).
  • [ISSN] 1028-8880
  • [Journal-full-title] Pakistan journal of biological sciences : PJBS
  • [ISO-abbreviation] Pak. J. Biol. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Pakistan
  • [Chemical-registry-number] 0 / Phenylacetates; 87-53-6 / Penicillanic Acid; EC 3.5.1.11 / Penicillin Amidase; ER5I1W795A / phenylacetic acid; QR0C4R7XVN / aminopenicillanic acid; S88TT14065 / Oxygen
  •  go-up   go-down


14. Riener MO, Stenner F, Liewen H, Soll C, Breitenstein S, Pestalozzi BC, Samaras P, Probst-Hensch N, Hellerbrand C, Müllhaupt B, Clavien PA, Bahra M, Neuhaus P, Wild P, Fritzsche F, Moch H, Jochum W, Kristiansen G: Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas. Hepatology; 2009 May;49(5):1602-9
Zurich Open Access Repository and Archive. Full text from .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.
  • Hepatocellular carcinomas (HCCs) and bile duct carcinomas (BDCs) have a poor prognosis.
  • A total of 97/114 (85%) BDCs showed a strong GOLPH2 expression which proved to be an independent prognostic factor for overall survival (P < 0.05).
  • [MeSH-major] Adenoma, Liver Cell / metabolism. Bile Duct Neoplasms / metabolism. Carcinoma, Hepatocellular / metabolism. Focal Nodular Hyperplasia / metabolism. Liver Neoplasms / metabolism. Membrane Proteins / metabolism

  • MedlinePlus Health Information. consumer health - Bile Duct Cancer.
  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Hepatology. 2009 Jul;50(1):325 [19492428.001]
  • [CommentIn] Hepatology. 2009 Jul;50(1):326 [19496179.001]
  • [CommentIn] Hepatology. 2009 May;49(5):1421-3 [19402061.001]
  • [CommentIn] Hepatology. 2009 Nov;50(5):1682 [19739256.001]
  • (PMID = 19291786.001).
  • [ISSN] 1527-3350
  • [Journal-full-title] Hepatology (Baltimore, Md.)
  • [ISO-abbreviation] Hepatology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / GOLM1 protein, human; 0 / Membrane Proteins
  •  go-up   go-down


15. Søreide K, Søreide JA: Bile duct cyst as precursor to biliary tract cancer. Ann Surg Oncol; 2007 Mar;14(3):1200-11
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Increasingly, BDCs are reported in the Western population, often with coexistent biliary tract cancer.
  • Pathological findings strongly suggest a hyperplasia-dysplasia-carcinoma sequence in carcinogenesis of pancreatico-biliary maljunction (PBM).
  • [MeSH-major] Bile Duct Diseases / pathology. Biliary Tract Neoplasms / diagnosis. Cysts / pathology


16. Hu TL, Zou RQ, Li JR, Bu XH: d(10) Metal complexes assembled from isomeric benzenedicarboxylates and 3-(2-pyridyl)pyrazole showing 1D chain structures: syntheses, structures and luminescent properties. Dalton Trans; 2008 Mar 14;(10):1302-11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In 1-7, the BDCs act as bridging ligands, exhibiting rich coordination modes to link metal ions.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18305842.001).
  • [ISSN] 1477-9226
  • [Journal-full-title] Dalton transactions (Cambridge, England : 2003)
  • [ISO-abbreviation] Dalton Trans
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


17. Santos LD, Kennerson AR, Killingsworth MC: Nodular hyperplasia of Bartholin's gland. Pathology; 2006 Jun;38(3):223-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Clinically, these lesions were described either as Bartholin's duct cysts (BDCs) or vulvar lumps.
  • There was no tumour recurrence or malignant transformation in eight patients with clinical follow-up.
  • [MeSH-minor] Adenoma / diagnosis. Adult. Biomarkers / metabolism. Diagnosis, Differential. Female. Humans. Hyperplasia. Middle Aged. Retrospective Studies. Secretory Vesicles / ultrastructure. Vulvar Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Vulvar Disorders.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16753743.001).
  • [ISSN] 0031-3025
  • [Journal-full-title] Pathology
  • [ISO-abbreviation] Pathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers
  •  go-up   go-down


18. Valdivielso M, Longo I, Suárez R, Huerta M, Lázaro P: Acrokeratosis paraneoplastica: Bazex syndrome. J Eur Acad Dermatol Venereol; 2005 May;19(3):340-4
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acrokeratosis paraneoplastica: Bazex syndrome.
  • Bazex syndrome is a paraneoplastic dermatosis characterized by acral psoriasiform lesions associated with an underlying neoplasm.
  • We present the case of a 64-year-old patient that was diagnosed with squamous cell lung carcinoma after being evaluated for lesions compatible with paraneoplastic acrokeratosis.
  • With a high frequency Bazex syndrome is the earliest marker of an underlying subclinical neoplasm.
  • An early suspicion is of the outmost importance in order to perform a prompt diagnosis of an underlying malignancy.
  • We propose a diagnostic algorithm upon suspicion of acrokeratosis paraneoplastica and review the pathogenesis of this entity.
  • [MeSH-major] Carcinoma, Squamous Cell / complications. Keratosis / pathology. Lung Neoplasms / complications. Paraneoplastic Syndromes / pathology
  • [MeSH-minor] Humans. Male. Middle Aged. Syndrome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15857461.001).
  • [ISSN] 0926-9959
  • [Journal-full-title] Journal of the European Academy of Dermatology and Venereology : JEADV
  • [ISO-abbreviation] J Eur Acad Dermatol Venereol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 29
  •  go-up   go-down


19. Ljubenovic MS, Ljubenovic DB, Binic II, Jankovic AS, Jovanovic DL: Acrokeratosis paraneoplastica (Bazex syndrome). Indian J Dermatol Venereol Leprol; 2009 May-Jun;75(3):329
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acrokeratosis paraneoplastica (Bazex syndrome).
  • Acrokeratosis paraneoplastica of Bazex is rare condition, characterized with scaly hyperkeratotic psoriasiform plaques on acral parts of body (helices, nose, and malar and acral surfaces), and in later stages propagation to the limbs and trunk.This syndrome is distinct marker for different neoplastic conditions, predominantly squamous cell carcinoma of the upper aerodigestive tract with possible cervical lymph node metastases.In this paper we present 56 years old male patient, with hyperkeratotic plaques on the skin of his palms, soles, ear lobes and apex of the nose.
  • Bazex syndrome can appear before the diagnosis of internal malignancies, and thus is important for dermatologists to recognize it in favor of early diagnosis of specific malignant process.
  • [MeSH-major] Keratosis / diagnosis. Paraneoplastic Syndromes / diagnosis
  • [MeSH-minor] Acrodermatitis / complications. Acrodermatitis / diagnosis. Fatal Outcome. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19439904.001).
  • [ISSN] 0973-3922
  • [Journal-full-title] Indian journal of dermatology, venereology and leprology
  • [ISO-abbreviation] Indian J Dermatol Venereol Leprol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


20. El Sayed F, Dhaybi R, Ammoury A, El Haddad B, Bazex J: [The syndrome of bazex or acrokeratosis paraneoplastica]. J Med Liban; 2006 Jan-Mar;54(1):28-31

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [The syndrome of bazex or acrokeratosis paraneoplastica].
  • [Transliterated title] Le syndrome de bazex ou acrokératose paranéoplasique. Revue de la littérature.
  • Bazex syndrome or acrokeratosis paraneoplastica is a rare dermatosis usually associated with a squamous cell carcinoma of upper aerodigestive tract or with metastases in the cervical lymph nodes.
  • This syndrome evolves in three stages parallel to the growth of the tumor, thus the utility of recognition of the syndrome which may unmask the associated neoplasia at an early stage.
  • [MeSH-major] Carcinoma, Squamous Cell / diagnosis. Carcinoma, Squamous Cell / therapy. Keratosis / diagnosis. Keratosis / therapy. Paraneoplastic Syndromes / diagnosis. Paraneoplastic Syndromes / therapy
  • [MeSH-minor] Ear, External / pathology. Head and Neck Neoplasms / pathology. Humans. Nails / pathology. Nose / pathology. Psoriasis. Syndrome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17044630.001).
  • [ISSN] 0023-9852
  • [Journal-full-title] Le Journal médical libanais. The Lebanese medical journal
  • [ISO-abbreviation] J Med Liban
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Lebanon
  • [Number-of-references] 24
  •  go-up   go-down


21. Medenica L, Gajić-Veljić M, Skiljević D, Pesko P: Acrokeratosis paraneoplastica Bazex syndrome associated with esophageal squamocellular carcinoma. Vojnosanit Pregl; 2008 Jun;65(6):485-7
MedlinePlus Health Information. consumer health - Skin Conditions.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acrokeratosis paraneoplastica Bazex syndrome associated with esophageal squamocellular carcinoma.
  • BACKGROUND: Acrokeratosis paraneoplastica Bazex (APB) is a very rare disease in the group of obligate paraneoplastic dermatoses, associated mostly with squamous cell carcinoma of the upper aerodigestive tract and metastatic cervical lymphadenopathy.
  • This entity was first reported by Bazex in 1965.
  • When the diagnosis was established, he did not have any symptom of internal malignancy.
  • Esophagogastroscopy revealed ulcerovegetant lesion of the esophagus, while histology showed squamocellular invasive carcinoma.
  • Surgical tumor removal resulted in significant improvement of skin changes in 15 days.
  • Unfortunately, four months later, extensive skin lesions pointed to metastasis of squamous cell carcinoma.
  • CONCLUSION: Skin changes can precede a few years the first manifestations of neoplasia.
  • [MeSH-major] Carcinoma, Squamous Cell / complications. Esophageal Neoplasms / complications. Paraneoplastic Syndromes / pathology. Skin Diseases / pathology

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18672707.001).
  • [ISSN] 0042-8450
  • [Journal-full-title] Vojnosanitetski pregled
  • [ISO-abbreviation] Vojnosanit Pregl
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Serbia
  •  go-up   go-down


22. Sharma V, Sharma NL, Ranjan N, Tegta GR, Sarin S: Acrokeratosis paraneoplastica (Bazex syndrome): case report and review of literature. Dermatol Online J; 2006;12(1):11

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acrokeratosis paraneoplastica (Bazex syndrome): case report and review of literature.
  • Acrokeratosis paraneoplastica of Bazex is a rare syndrome.
  • This condition is a distinct skin marker of supra-diaphragmatic neoplasia.
  • This syndrome is important because the cutaneous findings preceed the onset of symptoms referable to the underlying neoplasm by several months in majority of the cases.
  • We report here a case of a 63-year-old cachectic female who had classic psoriasiform lesions of acrokeratosis of Bazex with underlying bronchogenic carcinoma of the right lung.
  • [MeSH-major] Hand Dermatoses / pathology. Keratosis / pathology. Paraneoplastic Syndromes / pathology
  • [MeSH-minor] Carcinoma, Bronchogenic / radiography. Female. Humans. Lung Neoplasms / radiography. Lymphatic Metastasis / radiography. Middle Aged. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16638379.001).
  • [ISSN] 1087-2108
  • [Journal-full-title] Dermatology online journal
  • [ISO-abbreviation] Dermatol. Online J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 7
  •  go-up   go-down


23. Cabanillas M, Pérez-Pérez L, Sánchez-Aguilar D, Fernández-Redondo V, Toribio J: [Acrokeratosis paraneoplastica with bullous lesions associated with esophageal squamous cell carcinoma]. Actas Dermosifiliogr; 2006 Apr;97(3):196-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Acrokeratosis paraneoplastica with bullous lesions associated with esophageal squamous cell carcinoma].
  • [Transliterated title] Acroqueratosis paraneoplásica con lesiones ampollosas asociada a carcinoma epidermoide esofágico.
  • Acrokeratosis paraneoplastica (Bazex syndrome) is characterized by an acral eruption with a psoriasiform appearance, which usually presents simultaneously with an underlying neoplasm.
  • The digestive endoscopy revealed a squamous cell carcinoma in the proximal esophagus.
  • The histopathological study of the bullous lesions showed the presence of a subepidermal bulla, and direct immunofluorescence revealed granular deposits of IgG, IgA and C3 in the basal membrane of the healthy perilesional skin.
  • [MeSH-major] Acrodermatitis / etiology. Blister / etiology. Carcinoma, Squamous Cell / complications. Esophageal Neoplasms / complications. Keratosis / etiology. Paraneoplastic Syndromes / etiology
  • [MeSH-minor] Deglutition Disorders / etiology. Ear, External. Fatal Outcome. Hepatic Encephalopathy / etiology. Humans. Liver Neoplasms / complications. Liver Neoplasms / secondary. Male. Middle Aged. Pleural Effusion, Malignant / etiology. Wasting Syndrome / etiology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16796967.001).
  • [ISSN] 0001-7310
  • [Journal-full-title] Actas dermo-sifiliográficas
  • [ISO-abbreviation] Actas Dermosifiliogr
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


24. Fasanmade A, Farrell K, Perkins CS: Bazex syndrome (acrokeratosis paraneoplastica): persistence of cutaneous lesions after successful treatment of an associated oropharyngeal neoplasm. Br J Oral Maxillofac Surg; 2009 Mar;47(2):138-9
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bazex syndrome (acrokeratosis paraneoplastica): persistence of cutaneous lesions after successful treatment of an associated oropharyngeal neoplasm.
  • Acrokeratosis paraneoplastica is a rare paraneoplastic syndrome commonly affecting males over 40 years of age.
  • There exists a strong association with squamous cell carcinoma (SCC) of the upper aerodigestive tract or cervical metastatic disease originating from an unknown primary.
  • We report a case associated with SCC of the right tonsil with persistent paraneoplastic cutaneous lesions 2 years after successful treatment of the underlying neoplasm.
  • [MeSH-major] Hand Dermatoses / etiology. Keratosis / etiology. Paraneoplastic Syndromes / etiology. Tonsillar Neoplasms / complications

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18775590.001).
  • [ISSN] 1532-1940
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


25. Taher M, Grewal P, Gunn B, Tonkin K, Lauzon G: Acrokeratosis paraneoplastica (Bazex syndrome) presenting in a patient with metastatic breast carcinoma: possible etiologic role of zinc. J Cutan Med Surg; 2007 Mar-Apr;11(2):78-83
Hazardous Substances Data Bank. ZINC, ELEMENTAL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acrokeratosis paraneoplastica (Bazex syndrome) presenting in a patient with metastatic breast carcinoma: possible etiologic role of zinc.
  • BACKGROUND: Bazex syndrome (acrokeratosis paraneoplastica) is a rare paraneoplastic syndrome that usually occurs in males over 40 years old and is particularly associated with squamous cell carcinoma of the upper aerodigestive tract and adenopathy above the diaphragm.
  • OBJECTIVE: The objectives of our article are (1) to describe a unique case of acrokeratosis paraneoplastica and (2) to review the current literature regarding skin findings, commonly associated neoplasms, and treatment options relative to this condition.
  • PATIENT: We describe a 68-year-old female with lobular breast carcinoma, complicated by local and distant recurrences, who presented with a 1-year history of prominent acral skin and nail changes.
  • RESULTS: Our patient's clinical skin findings improved significantly following treatment and partial remission of her underlying malignancy.
  • CONCLUSIONS: Our patient represents one of few females described with this syndrome, which is especially rare in association with lobular breast carcinoma.
  • [MeSH-major] Breast Neoplasms / complications. Carcinoma, Lobular / complications
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans. Keratosis. Nail Diseases / etiology. Neoplasm Metastasis. Paraneoplastic Syndromes / diagnosis. Paraneoplastic Syndromes / etiology. Porphyria Cutanea Tarda / complications. Syndrome. Zinc / blood. Zinc / deficiency

  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17374318.001).
  • [ISSN] 1203-4754
  • [Journal-full-title] Journal of cutaneous medicine and surgery
  • [ISO-abbreviation] J Cutan Med Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] J41CSQ7QDS / Zinc
  •  go-up   go-down


26. Sator PG, Breier F, Gschnait F: Acrokeratosis paraneoplastica (Bazex's syndrome): association with liposarcoma. J Am Acad Dermatol; 2006 Dec;55(6):1103-5
Genetic Alliance. consumer health - Liposarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acrokeratosis paraneoplastica (Bazex's syndrome): association with liposarcoma.
  • Acrokeratosis paraneoplastica (Bazex's syndrome) is a rare obligate paraneoplastic dermatosis characterized by erythematosquamous lesions localized symmetrically at the acral sites.
  • It is usually associated with primary malignant neoplasms of the upper aerodigestive tract.
  • In most cases, the skin changes precede the clinical manifestation of the underlying neoplasm.
  • The dermatosis can be cured only by removal of the underlying carcinoma.
  • We describe a case of acrokeratosis paraneoplastica associated with a retroperitoneal liposarcoma in a 71-year-old Caucasian man.
  • The liposarcoma was surgically removed but recurred several times, with acrokeratosis paraneoplastica showing a parallel development.
  • We, therefore, add liposarcoma to the growing list of malignant neoplasms associated with acrokeratosis paraneoplastica.
  • [MeSH-major] Acrodermatitis / etiology. Keratosis / etiology. Liposarcoma / complications. Paraneoplastic Syndromes / etiology. Retroperitoneal Neoplasms / complications
  • [MeSH-minor] Aged. Combined Modality Therapy. Diagnosis, Differential. Humans. Male. Neoplasm Recurrence, Local / diagnosis. Neoplasm Recurrence, Local / radiotherapy. Neoplasm Recurrence, Local / surgery. Psoriasis / diagnosis. Radiotherapy, Adjuvant. Syndrome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Am Acad Dermatol. 2007 Jun;56(6):1065 [17504722.001]
  • (PMID = 17097409.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


27. Strobel ES, Bouveret C, Kohl PK: Acrokeratosis paraneoplastica of Bazex as an indicator for underlying squamous cell carcinoma of the lung. J Cancer Res Clin Oncol; 2006 Jun;132(6):376-8
MedlinePlus Health Information. consumer health - Skin Conditions.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acrokeratosis paraneoplastica of Bazex as an indicator for underlying squamous cell carcinoma of the lung.
  • PURPOSE: Obligatory cutaneous paraneoplastic disorders comprising acanthosis nigricans maligna, erythema gyratum repens, paraneoplastic pemphigus, hypertrichosis lanuginosa acquisita, erythema necrolyticum migrans and acrokeratosis paraneoplastica are rare.
  • Acrokeratosis paraneoplastica (first described by Gougerot and Rupp in 1922) was named after Bazex who had then reported several cases in a French dermatological journal since 1965 (Bazex et al. in Bull Soc Fr Dermatol Syphiligr 72:182, 1965; Bazex and Griffiths in Br J Dermatol 102:301-306, 1980).
  • METHOD: The study is a clinical case of a patient with acrokeratosis paraneoplastica.
  • RESULTS: the patient was later diagnosed with a cervical lymph node metastasis and thereafter with a primary squamous cell carcinoma of the left upper lobe and upon treatment responded with the clearing of the skin changes.
  • CONCLUSION: Identification of a paraneoplastic syndrome may enhance the earlier diagnosis of the associated tumor and may thus enable curative treatment.
  • [MeSH-major] Carcinoma, Squamous Cell / diagnosis. Lung Neoplasms / diagnosis. Paraneoplastic Syndromes / diagnosis. Skin Diseases / pathology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cutis. 2004 Nov;74(5):289-92 [15605965.001]
  • [Cites] Br J Dermatol. 1980 Sep;103(3):301-6 [7000146.001]
  • [Cites] J Am Acad Dermatol. 2005 Apr;52(4):711-2 [15793535.001]
  • [Cites] Clin Dermatol. 2005 May-Jun;23(3):301-6 [15896545.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1998;255(4):205-10 [9592679.001]
  • [Cites] J Drugs Dermatol. 2004 Sep-Oct;3(5):557-9 [15552609.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2005 May;19(3):340-4 [15857461.001]
  • [Cites] Semin Dermatol. 1995 Jun;14(2):84-9 [7640201.001]
  • [Cites] J Gastroenterol. 2000;35(6):460-4 [10864355.001]
  • (PMID = 16435144.001).
  • [ISSN] 0171-5216
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


28. Aksu G, Karadeniz A: Cutaneous paraneoplastic syndrome (acrokeratosis paraneoplastica) preceding squamous cell carcinoma of the glottic larynx. N Z Med J; 2006;119(1235):U2006
Genetic Alliance. consumer health - Carcinoma, Squamous Cell.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cutaneous paraneoplastic syndrome (acrokeratosis paraneoplastica) preceding squamous cell carcinoma of the glottic larynx.
  • Paraneoplastic syndromes that occur in the minority of cancer patients are the produced signs and symptoms at distant sites from the tumour or its metastases.
  • These syndromes may occur due to the production of substances by tumoural lesions that directly or indirectly cause distant symptoms or depletion of normal substances or host response to the tumours.
  • A paraneoplastic syndrome may be the first sign of a malignancy so its recognition may be critical for early cancer detection.
  • Most of the paraneoplastic syndromes associated with head and neck tumours are endocrinologic or neurologic; dermatologic syndromes are less common.
  • Head and neck cancers also have occasionally been reported in association with paraneoplastic syndromes and to date there are only a few cases in the literature about the presence of a cutaneous paraneoplastic syndrome as the first manifestation of a laryngeal cancer, especially glottic larynx cancer.
  • A wide variety of cutaneous syndromes are associated with malignancies and these syndromes may precede, follow, or be concurrent with the underlying malignancy.
  • In this report we present a case with cutaneous syndrome of acrokeratosis paraneoplastica preceding squamous cell carcinoma of glottic larynx, and review the other cutaneous paraneoplastic syndromes reported in the literature.
  • [MeSH-major] Acrodermatitis / etiology. Carcinoma, Squamous Cell / diagnosis. Laryngeal Neoplasms / diagnosis. Paraneoplastic Syndromes / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16751829.001).
  • [ISSN] 1175-8716
  • [Journal-full-title] The New Zealand medical journal
  • [ISO-abbreviation] N. Z. Med. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] New Zealand
  •  go-up   go-down


29. Santos-Silva AR, Correa MB, Vargas PA, Almeida OP, Lopes MA: Bazex syndrome (acrokeratosis paraneoplastica) diagnosed in a patient with oral persistent ulcerations. Head Neck Pathol; 2010 Dec;4(4):312-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bazex syndrome (acrokeratosis paraneoplastica) diagnosed in a patient with oral persistent ulcerations.
  • Paraneoplastic syndromes associated with head and neck cancer are rare and have been reported under dermatological, endocrine, hematological, neurological and rheumatological disorders.
  • Bazex syndrome is an intriguing paraneoplasia that can be associated with head and neck squamous cell carcinomas.
  • A range of symmetrical dermatological manifestations, with a clear predilection to extremities, that encompasses erythematous squamous plaques, skin scaling and nail dystrophy can provide a psoriasiform pattern in Bazex syndrome.
  • In addition to these tricky clinical features, the rarity of the disease and the lack of understanding on Bazex syndrome generally make such cases to be mismanaged as psoriasis or lichen planus, causing an important delay in the diagnosis of the underlying malignancy.
  • The authors describe a case of Bazex syndrome that occurred in a patient with a recently diagnosed tongue squamous cell carcinoma.
  • Clinicians should consider paraneoplasia when assessing skin and/or oral persistent lesions.
  • [MeSH-major] Onycholysis / pathology. Oral Ulcer / pathology. Paraneoplastic Syndromes / pathology. Skin Diseases, Papulosquamous / pathology
  • [MeSH-minor] Aneurysm / pathology. Carcinoma, Basal Cell / pathology. Fatal Outcome. Histiocytoma, Benign Fibrous / pathology. Humans. Hypotrichosis / pathology. Male. Middle Aged. Mucous Membrane / pathology. Penile Diseases / pathology. Skin / pathology. Skin Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Dermatol. 1984 Apr;120(4):502-4 [6703754.001]
  • [Cites] Medicine (Baltimore). 1991 Jul;70(4):269-80 [2067411.001]
  • [Cites] Br J Dermatol. 1995 Aug;133(2):322-5 [7547410.001]
  • [Cites] Eur Arch Otorhinolaryngol. 1998;255(4):205-10 [9592679.001]
  • [Cites] J Am Acad Dermatol. 1999 May;40(5 Pt 2):822-5 [10321625.001]
  • [Cites] Arch Dermatol. 1983 Oct;119(10):820-6 [6225397.001]
  • [Cites] Lancet. 2007 Feb 10;369(9560):530 [17292773.001]
  • [Cites] Dermatol Clin. 2008 Jan;26(1):17-29, vii [18023768.001]
  • [Cites] Australas J Dermatol. 2001 Nov;42(4):278-80 [11903162.001]
  • [Cites] Clin Exp Dermatol. 2004 Jul;29(4):430-2 [15245552.001]
  • [Cites] J Am Acad Dermatol. 2006 Dec;55(6):1103-5 [17097409.001]
  • (PMID = 20721648.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] Bazex-Dupre-Christol syndrome
  • [Other-IDs] NLM/ PMC2996492
  •  go-up   go-down


30. Abreu Velez AM, Howard MS: Diagnosis and treatment of cutaneous paraneoplastic disorders. Dermatol Ther; 2010 Nov-Dec;23(6):662-75
MedlinePlus Health Information. consumer health - Skin Conditions.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis and treatment of cutaneous paraneoplastic disorders.
  • The skin plays a critical role in the detection of internal malignances.
  • Cutaneous signs of these disorders afford clinicians opportunities for early diagnosis and treatment.
  • We aim to succinctly review the recognition, diagnosis, and treatment of selected cutaneous paraneoplastic diseases.
  • Skin disorders that may be associated with paraneoplastic syndromes include: cutaneous metastases, tripe palms, Sweet's syndrome, glucagonoma, Paget's disease and extramammary Paget's disease, acanthosis nigricans, Birt-Hogg-Dube syndrome, basal cell nevus syndrome, Bazex syndrome (acrokeratosis paraneoplastica), carcinoid syndrome, Cowden's disease(multiple hamartoma syndrome), dermatomyositis, erythema gyratum repens, ichthyosis aquisita, von Recklinghausen's disease, pityriasis rotunda, pyoderma gangrenosum, Quincke's edema (angioedema and paraneoplastic uricaria), paraneoplastic pemphigus, Degos' disease, superior vena cava syndrome, Werner's syndrome, diffuse normolipemic plane xanthomas, and yellow nail syndrome.
  • [MeSH-major] Paraneoplastic Syndromes / diagnosis. Paraneoplastic Syndromes / therapy. Skin Diseases / diagnosis. Skin Diseases / therapy
  • [MeSH-minor] Humans. Predictive Value of Tests. Skin / pathology. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 Wiley Periodicals, Inc.
  • (PMID = 21054710.001).
  • [ISSN] 1529-8019
  • [Journal-full-title] Dermatologic therapy
  • [ISO-abbreviation] Dermatol Ther
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Denmark
  •  go-up   go-down


31. Stone SP, Buescher LS: Life-threatening paraneoplastic cutaneous syndromes. Clin Dermatol; 2005 May-Jun;23(3):301-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Life-threatening paraneoplastic cutaneous syndromes.
  • Paraneoplastic syndromes are diseases or symptom complexes associated with malignancy, usually internal.
  • In this article, we discuss the link between malignancy and such dermatologic disorders as acanthosis nigricans, acrokeratosis paraneoplastica of Bazex, dermatomyositis, erythema gyratum repens, necrolytic migratory erythema (glucagonoma syndrome), and paraneoplastic pemphigus and discuss, where such information is known, the mechanism by which these paraneoplastic diseases occur.
  • [MeSH-major] Paraneoplastic Syndromes / diagnosis. Skin Diseases / diagnosis
  • [MeSH-minor] Critical Illness. Erythema / diagnosis. Humans. Neoplasms / diagnosis. Pemphigus / diagnosis

  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15896545.001).
  • [ISSN] 0738-081X
  • [Journal-full-title] Clinics in dermatology
  • [ISO-abbreviation] Clin. Dermatol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 54
  •  go-up   go-down


32. Schoeffler A, Sagot V, Marzin A, Brogniart P, Kanitakis J, Navailles B, Labeille B: [Bullous paraneoplastic acrokeratosis]. Ann Dermatol Venereol; 2006 Jun-Jul;133(6-7):557-60
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bullous paraneoplastic acrokeratosis].
  • BACKGROUND: Bullous lesions of acral distribution are an uncommon finding in Bazex's syndrome (acrokeratosis paraneoplastica).
  • PATIENTS AND METHODS: A 65 year-old-man, an alcoholic and a smoker, presented with characteristic lesions of Bazex's acrokeratosis paraneoplastica associated with a right cervical lymph node mass.
  • An epidermoid carcinoma of sinus piriformis was then discovered.
  • The acrokeratosis lesions worsened and spread to the knees, elbows, trunk and genitalia, with an erosive aspect, pain in the extremities, and tender, hemorrhagic bullous lesions on the toes and sides of the feet.
  • DISCUSSION: Although bullous lesions are rare in Bazex's syndrome (acrokeratosis paraneoplastica), they were noted as early as 1968 by Degos et al.
  • [MeSH-major] Keratosis / pathology. Paraneoplastic Syndromes / pathology. Skin Diseases, Vesiculobullous / pathology
  • [MeSH-minor] Aged. Carcinoma, Squamous Cell / diagnosis. Humans. Male. Nasopharyngeal Neoplasms / diagnosis

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16885844.001).
  • [ISSN] 0151-9638
  • [Journal-full-title] Annales de dermatologie et de vénéréologie
  • [ISO-abbreviation] Ann Dermatol Venereol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


33. Tartaglia F, Blasi S, Sgueglia M, Polichetti P, Tromba L, Berni A: Retroperitoneal liposarcoma associated with small plaque parapsoriasis. World J Surg Oncol; 2007;5:76
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Extremely rare cases of paraneoplastic syndromes or ectopic production of proteins associated with liposarcoma are reported in literature.
  • Production of Granulocyte-Colony Stimulating Factor, alpha-fetoprotein, paraneoplastic pemphigus and leucocytosis, Acrokeratosis paraneoplastica (Bazex's syndrome) are reported.
  • After surgery, the skin eruptions disappeared completely in seven days and so a diagnosis of parapsoriasis syndrome was done.
  • CONCLUSION: Parallel disappearing of skin eruptions after surgery, typical clinical picture and not specific histology of the cutaneous lesions suggest the diagnosis of small plaque parapsoriasis.
  • Therefore we propose to add Small Plaque Parapsoriasis to the list of paraneoplastic syndromes associated to liposarcoma.
  • [MeSH-major] Liposarcoma / complications. Paraneoplastic Syndromes / complications. Parapsoriasis / complications. Retroperitoneal Neoplasms / complications

  • Genetic Alliance. consumer health - Liposarcoma.
  • Genetic Alliance. consumer health - Parapsoriasis.
  • Genetic Alliance. consumer health - Retroperitoneal liposarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Am Acad Dermatol. 2006 Dec;55(6):1103-5 [17097409.001]
  • [Cites] J Clin Oncol. 2004 Jun 1;22(11):2242-3 [15169814.001]
  • [Cites] Am J Med. 1995 Dec;99(6):662-71 [7503090.001]
  • [Cites] Virchows Arch. 2006 Apr;448(4):517-20 [16489442.001]
  • [Cites] Intern Med. 1998 Oct;37(10):884-90 [9840715.001]
  • [Cites] Blood. 1999 Aug 15;94(4):1409-17 [10438729.001]
  • [Cites] Clin Dermatol. 2005 Nov-Dec;23(6):593-600 [16325068.001]
  • [Cites] Int J Dermatol. 1997 Jul;36(7):526-9 [9268753.001]
  • (PMID = 17620118.001).
  • [ISSN] 1477-7819
  • [Journal-full-title] World journal of surgical oncology
  • [ISO-abbreviation] World J Surg Oncol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1936423
  • [General-notes] NLM/ Original DateCompleted: 20070810
  •  go-up   go-down


34. Río Ramírez MT, Casado López ME, Peirón Puyal MJ, Peñas Herrero JM: [Pulmonary adenocarcinoma and Bazex syndrome (paraneoplastic acrokeratosis)]. Arch Bronconeumol; 2007 Jan;43(1):46-8
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Pulmonary adenocarcinoma and Bazex syndrome (paraneoplastic acrokeratosis)].
  • [Transliterated title] Adenocarcinoma de pulmón y síndrome de Bazex (acroqueratosis paraneoplásica).
  • Bazex syndrome, or paraneoplastic acrokeratosis, is a rare psoriasis-like paraneoplastic skin disease, characterized by erythema and scaling, which is accompanied by hyperkeratotic lesions.
  • The tumors most frequently associated with Bazex syndrome are squamous cell carcinomas of the upper respiratory and digestive tracts, whereas lung cancers, particularly adenocarcinomas, are rarely associated.
  • We present a case in which both pulmonary adenocarcinoma and Bazex syndrome were present.
  • [MeSH-major] Acrodermatitis / etiology. Adenocarcinoma / complications. Keratosis / etiology. Lung Neoplasms / complications. Paraneoplastic Syndromes / etiology
  • [MeSH-minor] Aged. Fatal Outcome. Foot Dermatoses / diagnosis. Foot Dermatoses / etiology. Hand Dermatoses / diagnosis. Hand Dermatoses / etiology. Humans. Lymphatic Metastasis. Male. Nail Diseases / diagnosis. Nail Diseases / etiology. Pruritus / etiology. Pulmonary Fibrosis / complications. Respiratory Insufficiency / complications. Syndrome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17257564.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


35. Moore RL, Devere TS: Epidermal manifestations of internal malignancy. Dermatol Clin; 2008 Jan;26(1):17-29, vii
MedlinePlus Health Information. consumer health - Skin Conditions.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Paraneoplastic syndromes with cutaneous findings localized to the epidermis are discussed in this article.
  • A paraneoplastic syndrome is a condition that arises in association with a malignancy elsewhere in the body but, in itself, is not cancerous.
  • Generally, the onset and course of the disease will closely correlate with the malignancy, as described in Curth's original criteria for paraneoplastic syndromes, although this is not always the case.
  • Subjects discussed include malignant acanthosis nigricans, the sign of Leser-Trélat, tripe palms, palmoplantar keratodermas, Bazex syndrome, and acquired ichthyosis.
  • [MeSH-major] Neoplasms / pathology. Paraneoplastic Syndromes / etiology. Skin Diseases / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18023768.001).
  • [ISSN] 0733-8635
  • [Journal-full-title] Dermatologic clinics
  • [ISO-abbreviation] Dermatol Clin
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 99
  •  go-up   go-down


36. Lee DA, Grossman ME, Schneiderman P, Celebi JT: Genetics of skin appendage neoplasms and related syndromes. J Med Genet; 2005 Nov;42(11):811-9
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genetics of skin appendage neoplasms and related syndromes.
  • In the past decade the molecular basis of many inherited syndromes has been unravelled.
  • This article reviews the clinical and genetic aspects of inherited syndromes that are characterised by skin appendage neoplasms, including Cowden syndrome, Birt-Hogg-Dube syndrome, naevoid basal cell carcinoma syndrome, generalised basaloid follicular hamartoma syndrome, Bazex syndrome, Brooke-Spiegler syndrome, familial cylindromatosis, multiple familial trichoepitheliomas, and Muir-Torre syndrome.

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Transplantation. 2004 Feb 27;77(4):574-9 [15084938.001]
  • [Cites] Trends Mol Med. 2004 Mar;10(3):136-41 [15102357.001]
  • [Cites] J Med Genet. 2004 May;41(5):323-6 [15121767.001]
  • [Cites] Mol Cancer. 2003 Dec 12;2:41 [14672538.001]
  • [Cites] Br J Surg. 1967 Mar;54(3):191-5 [6020987.001]
  • [Cites] J Med Genet. 1968 Mar;5(1):29-35 [5653864.001]
  • [Cites] Arch Dermatol. 1968 Nov;98(5):549-51 [5684233.001]
  • [Cites] Arch Dermatol. 1969 Apr;99(4):478-93 [4238829.001]
  • [Cites] Arch Dermatol. 1970 Dec;102(6):654-5 [5501907.001]
  • [Cites] Cancer. 1974 Mar;33(3):835-6 [4815585.001]
  • [Cites] J Invest Dermatol. 1974 Aug;63(2):212-8 [4843452.001]
  • [Cites] Arch Dermatol. 1974 Sep;110(3):473-4 [4375438.001]
  • [Cites] Br J Plast Surg. 1975 Oct;28(4):331-4 [1191881.001]
  • [Cites] Arch Dermatol. 1977 Dec;113(12):1674-7 [596896.001]
  • [Cites] Cancer. 1978 Jun;41(6):2393-8 [657103.001]
  • [Cites] Cancer. 1979 Dec;44(6):2294-305 [509397.001]
  • [Cites] Clin Exp Dermatol. 1983 Nov;8(6):603-12 [6661824.001]
  • [Cites] J Cutan Pathol. 1984 Oct;11(5):331-7 [6512062.001]
  • [Cites] Br J Dermatol. 1985 Sep;113(3):295-301 [4063166.001]
  • [Cites] Clin Genet. 1986 Mar;29(3):222-33 [3698331.001]
  • [Cites] Medicine (Baltimore). 1987 Mar;66(2):98-113 [3547011.001]
  • [Cites] Br J Plast Surg. 1987 Sep;40(5):528-31 [3676586.001]
  • [Cites] Ann Neurol. 1991 May;29(5):517-23 [1859181.001]
  • [Cites] J Am Acad Dermatol. 1991 May;24(5 Pt 1):715-9 [1869642.001]
  • [Cites] Lancet. 1992 Mar 7;339(8793):581-2 [1347096.001]
  • [Cites] Ann Dermatol Venereol. 1992;119(10):746-8 [1338355.001]
  • [Cites] Cancer. 1993 Sep 1;72(5):1618-23 [7688655.001]
  • [Cites] J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):189-206 [10906638.001]
  • [Cites] Cancer Res. 2000 Aug 1;60(15):4085-92 [10945614.001]
  • [Cites] J Med Genet. 2000 Nov;37(11):828-30 [11073535.001]
  • [Cites] J Am Acad Dermatol. 2000 Dec;43(6):1120-2 [11100034.001]
  • [Cites] J Invest Dermatol. 2001 Feb;116(2):246-53 [11180000.001]
  • [Cites] Dermatol Surg. 2001 Jan;27(1):67-70 [11231249.001]
  • [Cites] Hum Mol Genet. 2001 Apr;10(7):757-62 [11257109.001]
  • [Cites] Lancet. 2001 Jul 21;358(9277):210-1 [11476841.001]
  • [Cites] Oncogene. 2001 Aug 23;20(37):5239-42 [11526515.001]
  • [Cites] Am J Hum Genet. 2001 Oct;69(4):876-82 [11533913.001]
  • [Cites] Development. 2001 Oct;128(19):3843-53 [11585809.001]
  • [Cites] Ann Plast Surg. 2001 Jul;47(1):98-9 [11756818.001]
  • [Cites] J Am Acad Dermatol. 1993 Dec;29(6):1055-6 [8245249.001]
  • [Cites] J Med Genet. 1994 Jun;31(6):458-61 [8071972.001]
  • [Cites] Genomics. 1994 Dec;24(3):516-26 [7713503.001]
  • [Cites] J Am Acad Dermatol. 1995 Jul;33(1):90-104 [7601953.001]
  • [Cites] J Invest Dermatol. 1995 Jul;105(1):87-91 [7615983.001]
  • [Cites] J Am Acad Dermatol. 1995 Aug;33(2 Pt 1):199-206 [7622645.001]
  • [Cites] Nat Genet. 1995 Dec;11(4):441-3 [7493027.001]
  • [Cites] Nat Genet. 1996 May;13(1):114-6 [8673088.001]
  • [Cites] Science. 1996 Jun 14;272(5268):1668-71 [8658145.001]
  • [Cites] Cell. 1996 Jun 14;85(6):841-51 [8681379.001]
  • [Cites] Int J Dermatol. 1996 May;35(5):365-7 [8734663.001]
  • [Cites] Am J Hum Genet. 1996 Sep;59(3):736-9 [8751876.001]
  • [Cites] Am J Hum Genet. 1997 Jan;60(1):21-6 [8981943.001]
  • [Cites] J Dermatol. 1996 Nov;23(11):821-4 [8990706.001]
  • [Cites] Science. 1997 Mar 28;275(5308):1943-7 [9072974.001]
  • [Cites] Nat Genet. 1997 Apr;15(4):356-62 [9090379.001]
  • [Cites] Nat Genet. 1997 May;16(1):64-7 [9140396.001]
  • [Cites] Hum Pathol. 1998 Jan;29(1):47-53 [9445133.001]
  • [Cites] Hum Mol Genet. 1998 Mar;7(3):507-15 [9467011.001]
  • [Cites] Lupus. 1998;7(3):207-9 [9607646.001]
  • [Cites] Am J Hum Genet. 1998 Jul;63(1):63-70 [9634524.001]
  • [Cites] J Med Genet. 1999 May;36(5):360-4 [10353779.001]
  • [Cites] Hum Mol Genet. 1999 Aug;8(8):1461-72 [10400993.001]
  • [Cites] Am J Dermatopathol. 1999 Aug;21(4):369-74 [10446780.001]
  • [Cites] Arch Dermatol. 1999 Oct;135(10):1195-202 [10522666.001]
  • [Cites] N Engl J Med. 1960 May 5;262:908-12 [13851319.001]
  • [Cites] Dermatol Surg. 2000 Feb;26(2):152-4 [10691946.001]
  • [Cites] J Laryngol Otol. 1999 Aug;113(8):779-83 [10748863.001]
  • [Cites] Clin Cancer Res. 2000 May;6(5):1784-9 [10815898.001]
  • [Cites] Nat Genet. 2000 Jun;25(2):160-5 [10835629.001]
  • [Cites] Am J Hum Genet. 2002 Apr;70(4):829-44 [11875759.001]
  • [Cites] Cancer Epidemiol Biomarkers Prev. 2002 Apr;11(4):393-400 [11927500.001]
  • [Cites] Nat Rev Genet. 2002 Mar;3(3):199-209 [11972157.001]
  • [Cites] Br J Dermatol. 2002 Jun;146(6):1068-70 [12072080.001]
  • [Cites] Trends Mol Med. 2002 Jul;8(7):346-53 [12114115.001]
  • [Cites] J Invest Dermatol. 2002 Aug;119(2):527-31 [12190880.001]
  • [Cites] Cancer Cell. 2002 Aug;2(2):157-64 [12204536.001]
  • [Cites] J Cutan Pathol. 2002 Oct;29(9):529-33 [12358810.001]
  • [Cites] J Med Genet. 2002 Dec;39(12):906-12 [12471204.001]
  • [Cites] Nature. 2003 Feb 6;421(6923):639-43 [12571598.001]
  • [Cites] Am J Dermatopathol. 2003 Apr;25(2):130-7 [12652194.001]
  • [Cites] J Med Genet. 2003 May;40(5):364-7 [12746401.001]
  • [Cites] EMBO J. 2003 Jun 2;22(11):2741-51 [12773389.001]
  • [Cites] J Med Genet. 2003 Jul;40(7):511-5 [12843323.001]
  • [Cites] Cancer. 2003 Aug 1;98(3):618-24 [12879481.001]
  • [Cites] Nature. 2003 Aug 14;424(6950):793-6 [12917689.001]
  • [Cites] Nature. 2003 Aug 14;424(6950):797-801 [12917690.001]
  • [Cites] J Am Acad Dermatol. 2003 Oct;49(4):717-9 [14512924.001]
  • [Cites] Am J Med Genet A. 2003 Nov 15;123A(1):5-28 [14556242.001]
  • [Cites] J Invest Dermatol. 2003 Oct;121(4):732-4 [14632188.001]
  • [Cites] J Exp Med. 2003 Dec 15;198(12):1959-64 [14676304.001]
  • [Cites] J Dermatol. 2004 Jan;31(1):32-8 [14739501.001]
  • (PMID = 16272260.001).
  • [ISSN] 1468-6244
  • [Journal-full-title] Journal of medical genetics
  • [ISO-abbreviation] J. Med. Genet.
  • [Language] ENG
  • [Grant] United States / NIAMS NIH HHS / AR / K08 AR050273
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
  • [Publication-country] England
  • [Number-of-references] 95
  • [Other-IDs] NLM/ PMC1735949
  •  go-up   go-down


37. Alcalay J, Ben-Amitai D, Alkalay R: Idiopathic basal cell carcinoma in children. J Drugs Dermatol; 2008 May;7(5):479-81
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Idiopathic basal cell carcinoma in children.
  • Basal cell carcinoma (BCC) is the most common nonmelanoma skin cancer in humans, and is the most common malignant neoplasm among adults in the US.
  • Childhood onset of BCC is rare and usually associated with genetic disorders such as basal cell nevus syndrome, Bazex syndrome, albinism, and xeroderma pigmentosum or due to radiation therapy.
  • A total of 108 children including this patient were reported with idiopathic de novo BCC.
  • Basal cell carcinoma in children is probably the result of genetic background and intense ultraviolet radiation exposure.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Skin Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18505143.001).
  • [ISSN] 1545-9616
  • [Journal-full-title] Journal of drugs in dermatology : JDD
  • [ISO-abbreviation] J Drugs Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Griffin JR, Cohen PR, Tschen JA, Mullans EA, Schulze KE, Martinelli PT, Nelson BR: Basal cell carcinoma in childhood: case report and literature review. J Am Acad Dermatol; 2007 Nov;57(5 Suppl):S97-102
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Basal cell carcinoma in childhood: case report and literature review.
  • Childhood onset basal cell carcinoma is uncommon.
  • In addition to occurring in children with albinism, Bazex syndrome, basal cell carcinoma nevus syndrome, nevus sebaceus, radiotherapy-treated cancers, solid organ transplants, and xeroderma pigmentosum, childhood onset basal cell carcinoma has also occurred, albeit less commonly, de novo.
  • We describe a boy with idiopathic childhood onset basal cell carcinoma.
  • Previously published children with de novo basal cell carcinoma were collected from computerized medical literature search (PubMed) and citations from earlier reports.
  • To our knowledge, childhood onset idiopathic basal cell carcinoma has been observed in a total of 107 children, including our patient.
  • Basal cell carcinoma in children may be associated with prior sun exposure.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Nose Neoplasms / pathology. Skin Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Nasal Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17938034.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 61
  •  go-up   go-down


39. Yosipovitch G: Chronic pruritus: a paraneoplastic sign. Dermatol Ther; 2010 Nov-Dec;23(6):590-6
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Paraneoplastic pruritus has also been associated with solid tumors and is an important clinical symptom in paraneoplastic skin diseases such as erythroderma, Grovers disease, malignant acanthosis nigricans, generalized granuloma annulare, Bazex syndrome, and dermatomyositis.

  • MedlinePlus Health Information. consumer health - Itching.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 Wiley Periodicals, Inc.
  • [Cites] Cancer. 1983 May 15;51(10):1934-6 [6831358.001]
  • [Cites] Exp Dermatol. 2009 Jan;18(1):35-43 [19054054.001]
  • [Cites] Medicine (Baltimore). 1991 Jul;70(4):269-80 [2067411.001]
  • [Cites] Br J Dermatol. 1993 Sep;129(3):348-9 [8286239.001]
  • [Cites] Arch Dis Child. 1994 Feb;70(2):119-22 [8129432.001]
  • [Cites] Mayo Clin Proc. 1999 Mar;74(3):229-34 [10089990.001]
  • [Cites] Med Oncol. 1999 Jul;16(2):129-33 [10456661.001]
  • [Cites] Dermatol Ther. 2005 Jul-Aug;18(4):328-32 [16297005.001]
  • [Cites] J Allergy Clin Immunol. 2006 Feb;117(2):411-7 [16461142.001]
  • [Cites] J Am Acad Dermatol. 2006 Mar;54(3):527-31 [16488311.001]
  • [Cites] Nephrol Dial Transplant. 2006 Mar;21(3):749-55 [16249205.001]
  • [Cites] Int J Dermatol. 2006 Mar;45(3):251-6 [16533224.001]
  • [Cites] Nat Rev Neurosci. 2006 Jul;7(7):535-47 [16791143.001]
  • [Cites] J Am Acad Dermatol. 2006 Sep;55(3):543-4 [16908377.001]
  • [Cites] Pharmacol Biochem Behav. 2006 Sep;85(1):39-43 [16919318.001]
  • [Cites] J Am Acad Dermatol. 2009 Jan;60(1):39-50 [18842323.001]
  • [Cites] Acta Derm Venereol. 2009;89(1):45-51 [19197541.001]
  • [Cites] Eur J Dermatol. 2009 Jul-Aug;19(4):405-6 [19467976.001]
  • [Cites] Arch Pathol Lab Med. 2009 Sep;133(9):1490-4 [19722762.001]
  • [Cites] Science. 2009 Sep 18;325(5947):1531-4 [19661382.001]
  • [Cites] N Engl J Med. 2009 Oct 1;361(14):1415-6 [19797294.001]
  • [Cites] Br J Dermatol. 2009 Dec;161(6):1217-24 [19663869.001]
  • [Cites] Nephrol Dial Transplant. 2010 Apr;25(4):1251-7 [19926718.001]
  • [Cites] Int J Dermatol. 2010 Jan;49(1):1-11 [20465602.001]
  • [Cites] J Oncol Pharm Pract. 2010 Dec;16(4):223-32 [19910392.001]
  • [Cites] Br Med J. 1977 Mar 12;1(6062):687-8 [843873.001]
  • [Cites] J Am Acad Dermatol. 2001 Dec;45(6):892-6 [11712035.001]
  • [Cites] J Am Acad Dermatol. 2002 Jan;46(1):144-5 [11756965.001]
  • [Cites] J Pain Symptom Manage. 2003 Mar;25(3):288-91 [12614964.001]
  • [Cites] Am J Dermatopathol. 2003 Apr;25(2):113-6 [12652192.001]
  • [Cites] Scand J Gastroenterol. 2003 Jun;38(6):678-80 [12825879.001]
  • [Cites] J Pain Symptom Manage. 2003 Dec;26(6):1105-12 [14654262.001]
  • [Cites] Clin Exp Dermatol. 2004 May;29(3):273-6 [15115510.001]
  • [Cites] J Am Acad Dermatol. 2004 Jun;50(6):889-91 [15153889.001]
  • [Cites] Aust Fam Physician. 2004 Jul;33(7):495-9 [15301165.001]
  • [Cites] Medicine (Baltimore). 1968 Jan;47(1):33-51 [4868603.001]
  • [Cites] Leuk Lymphoma. 2007 May;48(5):855-65 [17487727.001]
  • [Cites] Acta Derm Venereol. 2007;87(4):295-8 [17598030.001]
  • [Cites] Pain. 2007 Sep;131(1-2):4-7 [17524558.001]
  • [Cites] Nature. 2007 Aug 9;448(7154):700-3 [17653196.001]
  • [Cites] J Dermatol. 2007 Sep;34(9):645-9 [17727368.001]
  • [Cites] J Neurosci. 2007 Sep 12;27(37):10007-14 [17855615.001]
  • [Cites] Int J Dermatol. 2007 Oct;46(10):1023-6 [17910707.001]
  • [Cites] Clin Exp Dermatol. 2007 Nov;32(6):752-4 [17868396.001]
  • [Cites] Dermatol Clin. 2008 Jan;26(1):17-29, vii [18023768.001]
  • [Cites] Am J Clin Dermatol. 2008;9(1):39-44 [18092842.001]
  • [Cites] Dermatol Ther. 2008 Jan-Feb;21(1):32-41 [18318883.001]
  • [Cites] J Neurosci. 2008 Apr 23;28(17):4331-5 [18434511.001]
  • [Cites] Am J Dermatopathol. 2008 Jun;30(3):274-7 [18496432.001]
  • [Cites] Cytokine. 2008 Jul;43(1):71-5 [18502145.001]
  • [Cites] J Neurosci. 2008 Jul 23;28(30):7659-69 [18650342.001]
  • [Cites] J Neurophysiol. 2008 Oct;100(4):2062-9 [18562548.001]
  • [Cites] Clin Cancer Res. 2008 Nov 1;14(21):6974-8 [18980992.001]
  • [Cites] J Am Acad Dermatol. 1988 Jan;18(1 Pt 1):149 [2964457.001]
  • (PMID = 21054705.001).
  • [ISSN] 1529-8019
  • [Journal-full-title] Dermatologic therapy
  • [ISO-abbreviation] Dermatol Ther
  • [Language] ENG
  • [Grant] United States / NIAMS NIH HHS / AR / R01 AR055902; United States / NIAMS NIH HHS / AR / 1R01AR055902-01A1
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antipruritics
  • [Other-IDs] NLM/ NIHMS304370; NLM/ PMC3150589
  •  go-up   go-down


40. Lo Muzio L: Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis; 2008;3:32
Genetic Alliance. consumer health - Nevoid basal cell carcinoma syndrome.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nevoid basal cell carcinoma syndrome (Gorlin syndrome).
  • Nevoid basal cell carcinoma syndrome (NBCCS), also known as Gorlin syndrome, is a hereditary condition characterized by a wide range of developmental abnormalities and a predisposition to neoplasms.
  • Main clinical manifestations include multiple basal cell carcinomas (BCCs), odontogenic keratocysts of the jaws, hyperkeratosis of palms and soles, skeletal abnormalities, intracranial ectopic calcifications, and facial dysmorphism (macrocephaly, cleft lip/palate and severe eye anomalies).
  • Clinical diagnosis relies on specific criteria.
  • Gene mutation analysis confirms the diagnosis.
  • Antenatal diagnosis is feasible by means of ultrasound scans and analysis of DNA extracted from fetal cells (obtained by amniocentesis or chorionic villus sampling).
  • Main differential diagnoses include Bazex syndrome, trichoepithelioma papulosum multiplex and Torre's syndrome (Muir-Torre's syndrome).
  • [MeSH-major] Basal Cell Nevus Syndrome
  • [MeSH-minor] Adolescent. Adult. Bone Neoplasms / epidemiology. Bone Neoplasms / genetics. Bone Neoplasms / pathology. Bone and Bones / abnormalities. Bone and Bones / radiography. Cerebellar Neoplasms / epidemiology. Cerebellar Neoplasms / genetics. Cerebellar Neoplasms / pathology. Child. Female. Humans. Male. Medulloblastoma / epidemiology. Medulloblastoma / genetics. Medulloblastoma / pathology. Odontogenic Cysts / epidemiology. Odontogenic Cysts / genetics. Odontogenic Cysts / pathology. Skin Neoplasms / epidemiology. Skin Neoplasms / genetics. Skin Neoplasms / pathology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Invest Dermatol. 2003 Sep;121(3):478-81 [12925203.001]
  • [Cites] Clin Exp Dermatol. 2003 Nov;28 Suppl 1:19-23 [14616807.001]
  • [Cites] Dermatol Surg. 2003 Dec;29(12):1236-40 [14725671.001]
  • [Cites] Cancer Res. 2004 Feb 1;64(3):934-41 [14871823.001]
  • [Cites] Arch Pathol Lab Med. 2004 Mar;128(3):313-7 [14987156.001]
  • [Cites] Int J Oral Maxillofac Surg. 2004 Jul;33(5):458-62 [15183409.001]
  • [Cites] J Dermatolog Treat. 2004 Apr;15(2):120-1 [15204165.001]
  • [Cites] Clin Exp Dermatol. 2004 Sep;29(5):542-4 [15347344.001]
  • [Cites] Hum Mutat. 2004 Nov;24(5):441 [15459969.001]
  • [Cites] Arch Fr Pediatr. 1968 Nov;25(9):1083-93 [5728392.001]
  • [Cites] Med Hist. 1969 Jul;13(3):294-7 [4893629.001]
  • [Cites] J Neurosurg. 1971 Nov;35(5):577-84 [5000945.001]
  • [Cites] Birth Defects Orig Artic Ser. 1971 Jun;7(8):140-8 [4950929.001]
  • [Cites] Acta Pathol Microbiol Scand A. 1976 Jan;84(1):107-12 [1251730.001]
  • [Cites] J Neurosurg. 1979 Jan;50(1):100-2 [758369.001]
  • [Cites] Cancer. 1979 Dec;44(6):2294-305 [509397.001]
  • [Cites] Br J Oral Surg. 1979 Nov;17(2):135-46 [298837.001]
  • [Cites] Hautarzt. 1981 Sep;32(9):455-8 [7275582.001]
  • [Cites] Cancer. 1982 Jan 15;49(2):350-3 [7053833.001]
  • [Cites] J Am Acad Dermatol. 1982 Apr;6(4 Pt 2 Suppl):815-23 [6950957.001]
  • [Cites] Ann Neurol. 1982 Apr;11(4):372-6 [7103417.001]
  • [Cites] Wien Klin Wochenschr. 1982 Sep 3;94(16):430-4 [7147982.001]
  • [Cites] Med Pediatr Oncol. 1983;11(3):178-9 [6855699.001]
  • [Cites] Am J Surg Pathol. 1984 Mar;8(3):231-6 [6703200.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1984 Feb;47(2):210-2 [6707662.001]
  • [Cites] Can Med Assoc J. 1985 May 1;132(9):1037-8 [3986729.001]
  • [Cites] N Engl J Med. 1986 Mar 13;314(11):700-6 [3951494.001]
  • [Cites] J Am Acad Dermatol. 1986 Nov;15(5 Pt 1):1023-30 [3537024.001]
  • [Cites] Medicine (Baltimore). 1987 Mar;66(2):98-113 [3547011.001]
  • [Cites] J Am Acad Dermatol. 1987 May;16(5 Pt 1):964-70 [3584581.001]
  • [Cites] J Comput Assist Tomogr. 1987 Sep-Oct;11(5):901-4 [3655059.001]
  • [Cites] Br J Plast Surg. 1987 Sep;40(5):528-31 [3676586.001]
  • [Cites] Am J Med Genet. 1997 Mar 31;69(3):299-308 [9096761.001]
  • [Cites] Am J Med Genet. 1997 Mar 31;69(3):309-14 [9096762.001]
  • [Cites] Cancer Res. 1997 Jun 15;57(12):2369-72 [9192811.001]
  • [Cites] Eur J Gynaecol Oncol. 2006;27(5):519-22 [17139991.001]
  • [Cites] Childs Nerv Syst. 2007 Jan;23(1):133-6 [16977487.001]
  • [Cites] Clin Exp Dermatol. 2007 Mar;32(2):202-3 [16780502.001]
  • [Cites] J Neurosurg. 2006 Oct;105(4 Suppl):315-20 [17328283.001]
  • [Cites] J Am Acad Dermatol. 2007 Aug;57(2 Suppl):S36-7 [17637368.001]
  • [Cites] Am J Otolaryngol. 2007 Sep-Oct;28(5):360-2 [17826543.001]
  • [Cites] J Drugs Dermatol. 2007 Sep;6(9):910-4 [17941362.001]
  • [Cites] Hum Genet. 2007 Dec;122(5):459-66 [17703323.001]
  • [Cites] Br J Cancer. 1997;76(2):141-5 [9231911.001]
  • [Cites] Ann Plast Surg. 1997 Oct;39(4):366-73 [9339279.001]
  • [Cites] Am J Med Genet. 1997 Dec 19;73(3):304-7 [9415689.001]
  • [Cites] Curr Opin Pediatr. 1997 Dec;9(6):630-5 [9425597.001]
  • [Cites] Hum Genet. 1997 Dec;101(3):317-22 [9439661.001]
  • [Cites] Laryngoscope. 1998 Feb;108(2):280-3 [9473082.001]
  • [Cites] Pediatr Hematol Oncol. 1998 Mar-Apr;15(2):187-91 [9592846.001]
  • [Cites] J Am Acad Dermatol. 1998 Aug;39(2 Pt 3):S82-5 [9703130.001]
  • [Cites] Hum Mol Genet. 1999 Feb;8(2):291-7 [9931336.001]
  • [Cites] Clin Genet. 1999 Jan;55(1):34-40 [10066029.001]
  • [Cites] J Am Dent Assoc. 1999 May;130(5):669-74 [10332131.001]
  • [Cites] Dermatologica. 1963;126:106-23 [13954184.001]
  • [Cites] N Engl J Med. 1960 May 5;262:908-12 [13851319.001]
  • [Cites] Genet Med. 2004 Nov-Dec;6(6):495-502 [15545745.001]
  • [Cites] Genet Med. 2004 Nov-Dec;6(6):530-9 [15545751.001]
  • [Cites] Ear Nose Throat J. 2004 Oct;83(10):716-8 [15586876.001]
  • [Cites] Ann Hum Genet. 2004 Nov;68(Pt 6):536-45 [15598212.001]
  • [Cites] Ann Plast Surg. 2004 Dec;53(6):593-5 [15602259.001]
  • [Cites] Arch Dermatol Res. 2005 Jan;296(7):303-8 [15565302.001]
  • [Cites] Neurol Med Chir (Tokyo). 2004 Dec;44(12):665-8 [15684600.001]
  • [Cites] Am J Med Genet A. 2005 Jan 30;132A(3):324-8 [15690381.001]
  • [Cites] Hum Mutat. 2005 Mar;25(3):322-3 [15712338.001]
  • [Cites] J Am Acad Dermatol. 2005 Nov;53(5 Suppl 1):S256-9 [16227103.001]
  • [Cites] Genet Med. 2005 Nov-Dec;7(9):611-9 [16301862.001]
  • [Cites] Prenat Diagn. 2005 Nov;25(11):997-9 [16231297.001]
  • [Cites] J Pathol. 2006 Jan;208(1):17-25 [16294371.001]
  • [Cites] Echocardiography. 2006 Jan;23(1):79-80 [16412193.001]
  • [Cites] Hum Mutat. 2006 Mar;27(3):215-9 [16419085.001]
  • [Cites] Ann Dermatol Venereol. 2006 Feb;133(2):117-23 [16508594.001]
  • [Cites] Tex Heart Inst J. 2006;33(1):88-90 [16572881.001]
  • [Cites] J Med Genet. 2006 Apr;43(4):e16 [16582078.001]
  • [Cites] Tumour Biol. 2006;27(4):175-80 [16675912.001]
  • [Cites] Lasers Surg Med. 2006 Jun;38(5):417-26 [16788928.001]
  • [Cites] Cancer Res. 2006 Jul 15;66(14):6964-71 [16849540.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2006 Aug;20(7):877-8 [16898919.001]
  • [Cites] Br J Cancer. 2006 Aug 21;95(4):548-53 [16909134.001]
  • [Cites] J Dent Res. 2006 Sep;85(9):859-63 [16931872.001]
  • [Cites] Dermatol Ther. 2006 Sep-Oct;19(5):306-14 [17014486.001]
  • [Cites] Dermatol Surg. 2002 Mar;28(3):287-90 [11896785.001]
  • [Cites] Oral Oncol. 2002 Jun;38(4):323-31 [12076694.001]
  • [Cites] Am J Med Genet. 2002 Jul 15;110(4):400-3 [12116218.001]
  • [Cites] Mol Genet Metab. 2002 May;76(1):57-61 [12175781.001]
  • [Cites] Hum Mutat. 2002 Sep;20(3):233-4 [12204003.001]
  • [Cites] J Dermatolog Treat. 2002 Sep;13(3):123-7 [12227875.001]
  • [Cites] Eur J Dermatol. 2002 Nov-Dec;12(6):569-72 [12459530.001]
  • [Cites] Jpn J Clin Oncol. 2003 Jan;33(1):47-50 [12604725.001]
  • [Cites] Clin Nucl Med. 2002 Dec;27(12):913-4 [12607884.001]
  • [Cites] Hum Mutat. 2003 Apr;21(4):451-2 [12655573.001]
  • [Cites] Am J Obstet Gynecol. 2003 Apr;188(4):1093-5 [12712116.001]
  • [Cites] J Am Acad Dermatol. 2003 May;48(5 Suppl):S64-6 [12734479.001]
  • [Cites] Pediatr Neurol. 2003 Mar;28(3):231-4 [12770681.001]
  • [Cites] Neuroradiology. 2003 Jun;45(6):390-2 [12756507.001]
  • [Cites] Cancer. 2003 Aug 1;98(3):618-24 [12879481.001]
  • [Cites] Nat Clin Pract Oncol. 2006 Oct;3(10):575-80 [17019435.001]
  • [Cites] J Clin Pathol. 2006 Oct;59(10):1084-6 [17021131.001]
  • [Cites] J Am Acad Dermatol. 2006 Nov;55(5 Suppl):S86-9 [17052541.001]
  • [Cites] Am J Med Genet A. 2006 Dec 1;140(23):2625-30 [16906569.001]
  • [Cites] AJNR Am J Neuroradiol. 2000 Apr;21(4):790-4 [10782799.001]
  • [Cites] Brain Dev. 2000 Jun;22(4):272-4 [10838118.001]
  • [Cites] J Mol Med (Berl). 2000;78(3):140-6 [10868476.001]
  • [Cites] J Dent Res. 2000 Jun;79(6):1418-22 [10890722.001]
  • [Cites] Cutis. 2000 Jul;66(1):35-8 [10916689.001]
  • [Cites] Arch Dermatol Res. 2000 Sep;292(9):475-6 [11000293.001]
  • [Cites] Br Dent J. 2001 Apr 14;190(7):349-50 [11338037.001]
  • [Cites] J Dermatol Sci. 2001 Sep;27(1):21-6 [11457640.001]
  • [Cites] Dermatologica. 1987;175 Suppl 1:138-44 [3480250.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Dec;64(6):727-30 [3480489.001]
  • [Cites] J Oral Pathol. 1988 Jan;17(1):39-42 [3131508.001]
  • [Cites] J Am Dent Assoc. 1988 Jun;116(7):887-9 [3164743.001]
  • [Cites] J Am Acad Dermatol. 1988 Jul;19(1 Pt 2):176-85 [3165982.001]
  • [Cites] Presse Med. 1988 Nov 26;17(42):2247-50 [2974590.001]
  • [Cites] Dentomaxillofac Radiol. 1987;16(2):99-103 [3333752.001]
  • [Cites] J Oral Maxillofac Surg. 1989 Jun;47(6):629-33 [2656943.001]
  • [Cites] J Am Acad Dermatol. 1989 Jul;21(1):144-5 [2745766.001]
  • [Cites] J Oral Maxillofac Surg. 1989 Aug;47(8):870-3 [2664107.001]
  • [Cites] J Dermatol Surg Oncol. 1989 Aug;15(8):868-71 [2754091.001]
  • [Cites] Int Surg. 1991 Jan-Mar;76(1):64-6 [2045256.001]
  • [Cites] Pediatr Radiol. 1991;21(3):234-5 [2047170.001]
  • [Cites] Genet Couns. 1990;1(3-4):273-7 [2098052.001]
  • [Cites] Am J Med Genet. 1991 Aug 1;40(2):206-10 [1910262.001]
  • [Cites] Br J Cancer. 1991 Nov;64(5):959-61 [1931625.001]
  • [Cites] Br J Neurosurg. 1991;5(6):643-6 [1772613.001]
  • [Cites] Lancet. 1992 Mar 7;339(8793):581-2 [1347096.001]
  • [Cites] Cancer Res. 1992 Mar 15;52(6):1494-8 [1540957.001]
  • [Cites] Genet Couns. 1991;2(3):157-62 [1801852.001]
  • [Cites] Cell. 1992 Apr 3;69(1):111-7 [1348213.001]
  • [Cites] Pediatr Pathol. 1992 Mar-Apr;12(2):255-62 [1570241.001]
  • [Cites] Pediatr Pathol. 1992 May-Jun;12(3):441-7 [1409143.001]
  • [Cites] Cesk Pediatr. 1993 Mar;48(3):129-32 [8495514.001]
  • [Cites] Dermatology. 1993;186(4):311-2 [8513207.001]
  • [Cites] J Med Genet. 1993 Jun;30(6):460-4 [8326488.001]
  • [Cites] Am J Hum Genet. 1993 Sep;53(3):760-7 [8352281.001]
  • [Cites] Hum Mol Genet. 1994 Mar;3(3):447-8 [8012356.001]
  • [Cites] Am J Med Genet. 1994 Apr 15;50(3):272-81 [8042672.001]
  • [Cites] Am J Med Genet. 1994 Apr 15;50(3):282-90 [8042673.001]
  • [Cites] Lancet. 1994 Aug 13;344(8920):477 [7914587.001]
  • [Cites] Bol Asoc Med P R. 1993 Jan-Mar;85(1-3):24-6 [8060441.001]
  • [Cites] Prenat Diagn. 1994 Aug;14(8):725-7 [7991513.001]
  • [Cites] Genomics. 1994 Aug;22(3):505-11 [8001963.001]
  • [Cites] Am J Pathol. 1995 Feb;146(2):472-80 [7856756.001]
  • [Cites] Pediatr Dermatol. 1994 Dec;11(4):323-6 [7899182.001]
  • [Cites] Dermatol Clin. 1995 Jan;13(1):113-25 [7712637.001]
  • [Cites] Br J Radiol. 1995 Apr;68(808):361-8 [7795971.001]
  • [Cites] Br J Radiol. 1995 Jun;68(810):596-9 [7627481.001]
  • [Cites] Nat Genet. 1996 Jan;12(1):85-7 [8528259.001]
  • [Cites] Arch Dermatol. 1996 Jan;132(1):94-5 [8546496.001]
  • [Cites] Neurology. 1996 Feb;46(2):574-6 [8614540.001]
  • [Cites] Science. 1996 Jun 14;272(5268):1668-71 [8658145.001]
  • [Cites] Cell. 1996 Jun 14;85(6):841-51 [8681379.001]
  • [Cites] Br J Ophthalmol. 1996 Apr;80(4):378 [8703894.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1996 May;32B(3):202-6 [8762878.001]
  • [Cites] Nat Genet. 1996 Sep;14(1):7-8 [8782809.001]
  • [Cites] Nat Genet. 1996 Sep;14(1):78-81 [8782823.001]
  • [Cites] Histopathology. 1996 Sep;29(3):247-52 [8884353.001]
  • [Cites] Nature. 1996 Nov 14;384(6605):129-34 [8906787.001]
  • [Cites] J Neurosurg. 1997 Feb;86(2):286-8 [9010431.001]
  • [Cites] Cancer Res. 1997 Mar 1;57(5):842-5 [9041183.001]
  • (PMID = 19032739.001).
  • [ISSN] 1750-1172
  • [Journal-full-title] Orphanet journal of rare diseases
  • [ISO-abbreviation] Orphanet J Rare Dis
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 164
  • [Other-IDs] NLM/ PMC2607262
  •  go-up   go-down


41. Chapireau D, Adlam D, Cameron M, Thompson M: Paraneoplastic syndromes in patients with primary oral cancers: a systematic review. Br J Oral Maxillofac Surg; 2010 Jul;48(5):338-44
MedlinePlus Health Information. consumer health - Oral Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paraneoplastic syndromes in patients with primary oral cancers: a systematic review.
  • The aim of this study was to review all the paraneoplastic syndromes of primary tumours of the oral cavity.
  • The primary search was conducted on PubMed, Scopus and EMBASE, and included every paraneoplastic syndrome from a primary oral tumour described in English, French, or German papers during the last 20 years.
  • The secondary search was conducted by handpicking articles from reviews on paraneoplastic syndromes of the head and neck.
  • We then cross-referenced "mouth neoplasm" with every paraneoplastic condition cited in relevant review articles.
  • We classified the paraneoplastic syndromes that arose from tumours of the head and neck into six categories: endocrine, dermatological, vascular and haematological, rheumatoid, ocular, and neurological.
  • The following conditions are described in this review: syndrome of inappropriate antidiuretic hormone production, hypercalcaemia, hypercalcaemia-leucocytosis syndrome, ectopic production of beta-human chorionic gonadotrophin, Bazex syndrome, Sweet syndrome, tripe palm syndrome, pemphigus, pityriasis rotunda, neutrophilic leukemoid reaction, cerebral venous sinus thrombophlebitis, digital ischaemia, dermatomyositis, necrotising myopathy, autoimmune retinal degeneration, and subacute cerebellar degeneration.
  • Paraneoplastic syndromes of the oral cavity are a heterogeneous group.
  • Most syndromes occur from squamous cell carcinoma and their aetiology is poorly understood.
  • They are important to recognise as they can be the presenting complaint of a malignant tumour, change the prognosis, and considerably reduce the quality of life.
  • [MeSH-major] Carcinoma, Squamous Cell / complications. Mouth Neoplasms / complications. Paraneoplastic Syndromes / etiology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 19833419.001).
  • [ISSN] 1532-1940
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Scotland
  • [Number-of-references] 59
  •  go-up   go-down


42. Poligone B, Christensen SR, Lazova R, Heald PW: Bazex syndrome (acrokeratosis paraneoplastica). Lancet; 2007 Feb 10;369(9560):530
Hazardous Substances Data Bank. FLUOROURACIL .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bazex syndrome (acrokeratosis paraneoplastica).
  • [MeSH-major] Carcinoma, Squamous Cell / therapy. Esophageal Neoplasms / therapy. Paraneoplastic Syndromes / etiology. Skin Diseases / etiology

  • MedlinePlus Health Information. consumer health - Esophageal Cancer.
  • MedlinePlus Health Information. consumer health - Skin Conditions.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CIS-DIAMINEDICHLOROPLATINUM .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17292773.001).
  • [ISSN] 1474-547X
  • [Journal-full-title] Lancet (London, England)
  • [ISO-abbreviation] Lancet
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] Q20Q21Q62J / Cisplatin; U3P01618RT / Fluorouracil
  •  go-up   go-down


43. Louvel G, Vauléon E, Boucher E, Raoul JL: Acrokeratosis paraneoplastica (Bazex' syndrome) associated with metastatic squamous cell esophageal carcinoma. J Clin Oncol; 2008 Nov 1;26(31):5128-9
MedlinePlus Health Information. consumer health - Esophageal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acrokeratosis paraneoplastica (Bazex' syndrome) associated with metastatic squamous cell esophageal carcinoma.
  • [MeSH-major] Carcinoma, Squamous Cell / pathology. Esophageal Neoplasms / pathology. Keratosis / pathology. Paraneoplastic Syndromes / pathology
  • [MeSH-minor] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Disease Progression. Fatal Outcome. Humans. Male. Middle Aged. Neoplasm Metastasis. Treatment Failure

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18838705.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Viteri A, Muñoz A, Barcelò R: Acrokeratosis paraneoplastica (Bazex syndrome) preceeding the diagnosis of metastatic squamous cell carcinoma of the esophagus. J Am Acad Dermatol; 2005 Apr;52(4):711-2
MedlinePlus Health Information. consumer health - Esophageal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acrokeratosis paraneoplastica (Bazex syndrome) preceeding the diagnosis of metastatic squamous cell carcinoma of the esophagus.
  • [MeSH-major] Carcinoma, Squamous Cell / secondary. Esophageal Neoplasms / pathology. Keratosis / etiology. Paraneoplastic Syndromes / etiology

  • Genetic Alliance. consumer health - Carcinoma, Squamous Cell.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15793535.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down


45. Torrelo A, Sprecher E, Mediero IG, Bergman R, Zambrano A: What syndrome is this? Bazex-Dupre-Christol syndrome. Pediatr Dermatol; 2006 May-Jun;23(3):286-90
MedlinePlus Health Information. consumer health - Skin Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] What syndrome is this? Bazex-Dupre-Christol syndrome.
  • [MeSH-major] Carcinoma, Basal Cell / pathology. Hair Follicle / pathology. Hypotrichosis / pathology. Skin Neoplasms / pathology
  • [MeSH-minor] Atrophy / pathology. Humans. Infant. Male. Syndrome

  • Genetic Alliance. consumer health - Bazex-Dupre-Christol Syndrome.
  • MedlinePlus Health Information. consumer health - Hair Loss.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16780482.001).
  • [ISSN] 0736-8046
  • [Journal-full-title] Pediatric dermatology
  • [ISO-abbreviation] Pediatr Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


46. Sallés M, Riera E, Fuente MJ, Olivé A: [Bazex syndrome, polymyalgia rheumatica or shoulder girdle syndrome?]. Med Clin (Barc); 2005 Apr 23;124(15):596
MedlinePlus Health Information. consumer health - Polymyalgia Rheumatica.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Bazex syndrome, polymyalgia rheumatica or shoulder girdle syndrome?].
  • [Transliterated title] Síndrome de Bazex, polimialgia reumática o síndrome de cinturas?
  • [MeSH-major] Brachial Plexus Neuritis / diagnosis. Brachial Plexus Neuritis / physiopathology. Polymyalgia Rheumatica / diagnosis. Polymyalgia Rheumatica / physiopathology
  • [MeSH-minor] Aged. Carcinoma, Squamous Cell / complications. Humans. Male. Middle Aged. Psoriasis / complications. Syndrome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15860179.001).
  • [ISSN] 0025-7753
  • [Journal-full-title] Medicina clínica
  • [ISO-abbreviation] Med Clin (Barc)
  • [Language] spa
  • [Publication-type] Case Reports; Comparative Study; Letter
  • [Publication-country] Spain
  •  go-up   go-down


47. Dauendorffer JN, Bourgeois-Droin C: [Paraneoplastic acrokeratosis (Bazex syndrome)]. Ann Dermatol Venereol; 2006 Dec;133(12):1032-3

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Paraneoplastic acrokeratosis (Bazex syndrome)].
  • [Transliterated title] Acrokératose paranéoplasique (syndrome de Bazex).
  • [MeSH-major] Keratosis / diagnosis. Paraneoplastic Syndromes / diagnosis
  • [MeSH-minor] Abdominal Neoplasms / diagnosis. Carcinoma, Neuroendocrine / diagnosis. Carcinoma, Squamous Cell / diagnosis. Ear, External / pathology. Foot Dermatoses / etiology. Hand Dermatoses / etiology. Humans. Male. Mandibular Neoplasms / diagnosis. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17185944.001).
  • [ISSN] 0151-9638
  • [Journal-full-title] Annales de dermatologie et de vénéréologie
  • [ISO-abbreviation] Ann Dermatol Venereol
  • [Language] fre
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


48. Crucitti A, Feliciani C, Grossi U, La Greca A, Porziella V, Giustacchini P, Congedo MT, Fronterré P, Granone PM: Paraneoplastic acrokeratosis (bazex syndrome) in lung cancer. J Clin Oncol; 2009 Dec 20;27(36):e266-8
MedlinePlus Health Information. consumer health - Lung Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paraneoplastic acrokeratosis (bazex syndrome) in lung cancer.
  • [MeSH-major] Adenocarcinoma / diagnosis. Keratosis / diagnosis. Lung Neoplasms / diagnosis. Paraneoplastic Syndromes / diagnosis

  • Genetic Alliance. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19826120.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


49. Rudolph RI: Bazex syndrome or dermatomyositis? J Am Acad Dermatol; 2007 Jun;56(6):1065
Genetic Alliance. consumer health - Dermatomyositis.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Bazex syndrome or dermatomyositis?
  • [MeSH-major] Acrodermatitis / diagnosis. Dermatomyositis / diagnosis. Keratosis / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Humans. Liposarcoma / complications. Retroperitoneal Neoplasms / complications. Syndrome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] J Am Acad Dermatol. 2006 Dec;55(6):1103-5 [17097409.001]
  • (PMID = 17504722.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] United States
  •  go-up   go-down


50. Niitani A, Matsuura H, Kuyama M, Fujimoto W: Paraneoplastic dermatosis suspected of being Bazex syndrome in a woman with breast cancer. Eur J Dermatol; 2007 Nov-Dec;17(6):557-8
MedlinePlus Health Information. consumer health - Skin Conditions.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Paraneoplastic dermatosis suspected of being Bazex syndrome in a woman with breast cancer.
  • [MeSH-major] Breast Neoplasms / complications. Carcinoma, Ductal, Breast / complications. Keratoderma, Palmoplantar / etiology. Paraneoplastic Syndromes / etiology. Skin Diseases / etiology

  • Genetic Alliance. consumer health - Breast Cancer.
  • MedlinePlus Health Information. consumer health - Breast Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17951155.001).
  • [ISSN] 1167-1122
  • [Journal-full-title] European journal of dermatology : EJD
  • [ISO-abbreviation] Eur J Dermatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] France
  •  go-up   go-down


51. da Rosa AC, Pinto GM, Bortoluzzi JS, Duquia RP, de Almeida HL Jr: Three simultaneous paraneoplastic manifestations (ichthyosis acquisita, Bazex syndrome, and Leser-Trélat sign) with prostate adenocarcinoma. J Am Acad Dermatol; 2009 Sep;61(3):538-40
MedlinePlus Health Information. consumer health - Prostate Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Three simultaneous paraneoplastic manifestations (ichthyosis acquisita, Bazex syndrome, and Leser-Trélat sign) with prostate adenocarcinoma.
  • [MeSH-major] Adenocarcinoma / complications. Ichthyosis / etiology. Keratosis, Seborrheic / etiology. Paraneoplastic Syndromes / pathology. Prostatic Neoplasms / complications

  • Genetic Alliance. consumer health - Ichthyosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19700026.001).
  • [ISSN] 1097-6787
  • [Journal-full-title] Journal of the American Academy of Dermatology
  • [ISO-abbreviation] J. Am. Acad. Dermatol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  •  go-up   go-down






Advertisement